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Daptomycin (dap) is calcium-dependent lipopeptide antibiotic that is used clinically to treat systemic 
infections caused by Gram-positive pathogens. It is thought that dap brings about its antimicrobial 
effect by binding cytoplasmic bacterial membranes, via a calcium meditated interaction with the lipid 
phosphatidylglycerol (PG), and subsequent oligomerization. There is consensus that dap 
oligomerization is required for bactericidal activity, but the exact mechanism by which dap oligomers 
cause cell death is contested. Significant experimental evidence suggests that dap oligomers form 
cation-selective pores that cause membrane depolarization halting metabolite transport and resulting in 
cell death. Other proposed action modes include dap-induced non-selective membrane 
permeabilization, lipid extraction, and dislodgement of membrane-associated biosynthetic enzymes. 
The effect of phospholipids acyl tails on dap cation-selective pore formation has not been studied. In 
this thesis, fluorescence spectroscopy experiments on large unilamellar vesicles were used to study the 
effects of phospholipid acyl tails on dap cation-selective pore formation in a systematic fashion. It was 
observed that dap could permeabilize membranes composed of equal parts PC and PG with myristoyl      
acyl tails, but not those containing palmitoyl and oleoyl acyl tails. Oleoyl lipid acyl tails were found to 
render membranes insusceptible to dap pore formation regardless of the headgroup they were ligated 
to and at low concentrations in the membrane (10 mol%). Further studies showed that inhibition of dap 
pore formation by phospholipid acyl tails is correlated with increased acyl tail length rather than lipid 
unsaturation. Oleoyl acyl tails were found to restrict dap pore formation by disrupting the final stage of 
oligomer assembly. Attempts to permeabilize oleoyl lipid acyl tail containing membranes by branching 
and increasing the length of dap’s acyl tail moiety were unsuccessful. Overall, these findings suggest 
that lipid acyls affect dap’s action mode and should be a major consideration when designing model 
membrane systems for future dap action mode studies.  
Determining dap’s membrane-bound structure at an atomic level would help resolve the debate in 
literature regarding its action mode and establish dap’s structure-activity relationship. Previous 
attempts to determine the membrane-bound structure by solution-state nuclear magnetic resonance have 
failed because no suitable membrane mimetic existed. The latter portion of this thesis investigated the 
suitability of novel styrene-maleic acid (SMA) co-polymers to create membrane nanodisc suitable for 
determining dap’s membrane-bound structure. Through dynamic light scattering, fluorescence 
spectroscopy, and solution-state NMR it was found that this polymer can form membrane nanodiscs, 
 
 iv 
with a diameter small enough for structural studies by solution-state NMR, in the presence of PG (50 
mol%) and 3 mM calcium. Further, these PG containing nanodiscs allow for partially dap 
oligomerization, and are stable on the timescale of NMR experiments. Overall, while the SMA polymer 
used in this study did not allow for full dap oligomerization, the partial structure of membrane-bound 
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Chapter 1            






The goal of this work is to further investigate the action mode of the lipopeptide antibiotic daptomycin 
(dap). Before discussing, in depth, the specific questions investigated, it is important to briefly discuss 
previous research regarding dap’s action mode.  
1.1 Brief History of Daptomycin 
Dap is clinically used, as a drug of last resort, to treat infections caused by Gram-positive pathogens.1 
It is a calcium-dependent lipopeptide antibiotic that brings about its bactericidal effect by targeting the 
cytoplasmic membranes of Gram-positive pathogens such as Staphylococcus aureus and Enterococcus 
faecalis.1 Dap is a part of the A21978C family of lipopeptide antibiotics that was discovered by 
researchers from Eli Lilly in the early 1980’s. The A21978C family is biosynthesized by the soil 
bacterium Streptomyces roseosporus through the action of non-ribosomal peptide synthetases.2  
1.2 Structure of Daptomycin and the A21978C Family  
Each member of the A21978C family consists of a conserved 13 amino acid peptide moiety; the 
variation between members only pertains to the variable fatty acid tail attached at the N-terminus.2 The 
conserved peptide portion consists of a ten amino acid macrocycle closed by an ester bond and a tri-
amino acid exocyclic portion that bears the fatty acid moiety.2 It is noteworthy that the conserved 
peptide moiety contains 6 non-proteogenic amino acids - 3 D-amino acids, which in Figure 1 are 
highlighted in blue, 3 L-amino acids which are highlighted in red, and two intrinsically fluorescent 
amino acids: trptophan-1 and kynurenine-13 ( see Figure.1-1, Panel B). In solution, at physiological 




In its native environment, Streptomyces roseosporus produces 3 variants of the A21978C family (see 
Figure. 1-1 , Panel A).2 Debono et al.(1988) found that while all 3 natural A21978C variants were 
potent antimicrobials they were also quite toxic.  The remarkably low lethal dose 50 (LD50) values 
exhibited by these compounds were a major obstacle that had to be overcome in order to make the 
A21978C family viable for clinical use. Upon further investigation, Debono et al. (1988) found that the 
antimicrobial activity and toxicity of the A21978C family could be controlled by altering the length 
and branching of the fatty acid moiety; derivatives with short acyl tails and no branching had slightly 
lower minimum inhibitory concentrations (MIC), but toxicity was more strongly reduced; the most 
favorable ratio of toxicity to antimicrobial activity was found with a decanoyl fatty acid tail. The 
combination of the conserved peptide moiety attached to a decanoyl fatty acid acyl tail was named 
daptomycin.    
 
 
Figure 1-1. Structure of daptomycin. Panel A shows the decanoyl fatty acid moiety along the three most 
common analogues produced naturally by Streptomyces roseosporus. Panel B shows the peptide moiety 
shared between A21978C family members. Panel C details the pKa of the peptide moieties various 
ionizable side chains.  
1.3  Action Mechanism of Daptomycin 
Despite being discovered nearly 40 years ago and seeing extensive clinical use since 2003, the 
mechanism by which dap brings about its antimicrobial effect is still subject to much debate.3–5 There 
is consensus that dap’s antimicrobial effect is brought about by membrane-embedded oligomers that 




phosphatidylglycerol1 (PG).6–9 The debate surrounding dap’s action mode specifically revolves around 
firmly establishing  how exactly dap oligomers bring about microbial death. 
Before discussing dap’s proposed action modes in detail, a brief description of a Gram-positive 
bacteria’s cell envelope is required. The cell envelope of Gram-positive bacteria comprises a cell wall 
and the cytoplasmic membrane. The cell wall consists of thick peptidoglycan layer and  encapsulates 
the inner cytoplasmic membrane (see Figure.1-2).10 The cytoplasmic membranes of Gram-positive 
bacteria, that are susceptible to daptomycin, are composed of phospholipids with phosphatidylglycerol 
(PG) being quite prevalent.11,12 The acyl tails of the phospholipids are quite varied with the most 
abundant acyl tail being 14 carbons long with a single methylation at the 3 third position from the 
terminal carbon (See Appendix A Figure 5 for a detailed chart of bacterial acyl tail composition).13  
 
 
Figure 1-2. Cellular envelopes of Gram-positive and negative bacteria. This Figure shows the difference 
between the cellular envelopes of Gram-positive and Gram-negative bacteria.14  
1.3.1 Daptomycin’s binding to the cytoplasmic membrane 
Before interacting with the cytoplasmic membrane of a Gram-positive bacterium dap must traverse the 
bacterium’s thick murein layer. Taylor et al. (2017) found that dap had a lower minimum inhibitory 
                                                   
1 The structures of all lipids and dap derivatives can be found in Appendix D. 
 
 4 
concentration (.075 µg/ml vs .5 µg/ml) on Gram-positive bacterial cells lacking a cell wall (L-forms) 
than against  intact cells of the same species.10 These data suggest that while the cell wall does sequester 
some dap molecules it is not a major obstacle in dap’s journey to the cytoplasmic membrane.  
Once dap has reached the cytoplasmic membrane it interacts with the anionic phospholipid PG. Dap’s 
preference for PG has been demonstrated by a variety of experiments, but the most thorough studies 
were conducted by Jung et al. (2004), who utilized circular dichroism to show that on large unilamellar 
vesicles (LUVs) dap’s secondary structure undergoes conformational changes, indicative of membrane-
binding, only in the presence of PG and physiological concentrations of calcium (≈ 1.25 mM).6 The 
requirement  for PG was rather surprising, considering that at physiological pH both dap and PG are 
anionic. Jung et al. (2004) rationalized the interaction by proposing that calcium mediates it by acting 
as an electrostatic shield. Muraih et al. (2011) further investigated the role of PG in dap’s interaction 
with bacterial membranes by utilized fluorescence spectroscopy.9 Muraih et al. (2011) found that dap 
could interact with membranes lacking PG, but at calcium concentrations 2 orders of magnitude greater 
than those required to observe binding of dap to PG containing membranes.9 
1.3.2 Daptomycin brings about bacterial death by permeabilizing membranes in a 
cation-selective fashion 
It is generally accepted that dap brings about bacterial death via cation-selective pore formation. The 
idea was first suggested by Alborn et al. (1991), who showed that Staphylococcus aureus cells 
experience membrane depolarization upon treatment with calcium and dap (recently dap-induced 
membrane depolarization  was observed on  Bacillus subtilis cells suggesting that cation-pore formation 
is likely a general action mechanism).15,16 Several years later Silverman et al. (2003), confirmed this 
mode of action by showing that Staphylococcus aureus cells began to release intracellular potassium 
upon addition of calcium and daptomycin.7 In vitro on LUVs, Zhang et al (2014) found that dap’s pores 
are selective for monovalent-cations and some divalent-cations (organic cations were also transported 
by dap’s pores, but not efficiently).17 Most recently, the existence of dap cation-selective pores was 
proven empirically by Seydlová et al. (2018); through conductance measurements on planar lipid 
bilayers they observed that dap gives rise to discrete conductance events indicative of cation-selective 
pores.16 They further established that dap’s propensity to form said cation-selective pores and their rate 
of transport correlates with membrane potential.  
It was Muraih et al. (2011) and Muraih et al. (2012) who made the very important discovery that dap 
oligomerizes on membranes. Through fluorescence resonance energy transfer (FRET) studies 
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conducted on LUVs, with fluorescently labelled dap derivatives, they determined that once monomeric 
dap binds to the membrane it forms oligomers of approximately 8 dap molecules.9,18 Dap 
oligomerization was observed only on membranes containing PG.9  Later,  Zhang et al. in 2013 found    
oligomer formation to be a requirement for bactericidal activity.19  
At the time of their studies, Muraih et al. (2012) speculated that the dap octamer might consist of two 
dap tetramers conjoining across opposing membrane leaflets. The assumption was proven true by 
Zhang et al. (2014).20  Whilst investigating the inhibitory effects of cardiolipin on  dap oligomer cation-
selective pore formation, Zhang et al. (2014) found that dap’s ability to permeabilize CL containing 
LUVs correlated with oligomer size.20 They observed that on CL containing LUVs, daptomycin was 
restricted to the outer leaflet; oligomers still formed but consisted of 4 subunits.20 In contrast, LUVs 
readily permeabilized by dap, such as those comprised of 1:1 DMPC: DMPG, had equal distribution of 
dap between membrane leaflets and oligomers containing 8 dap molecules. The increased subunit 
stoichiometry on susceptible LUVs suggested that the dap octamer is formed via a trans-membrane 
interaction of two tetrameric oligomers located on opposing membrane leaflets. Additionally, these 
data suggest that the octamer constitutes the functional cation-selective pore that is essential for 
antimicrobial activity.20  
The role played by calcium in dap’s binding to PG and subsequent oligomerization was investigated in 
depth by Taylor et al. (2016) and Zhang et al. (2016).8,21 Taylor et al. (2016) utilized isothermal 
calorimetry (ITC) to show that formation of the membrane-embedded octamer requires each dap 
molecule to bind two calcium ions.  The ITC results suggest that the two cations are bound in a 
sequential fashion by two different binding sites on dap.8 The work with fluorescently labeled dap 
analogs and derivatives by Taylor et al. (2016)  and Zhang et al. (2016) suggests that the first calcium 
binding event results in the formation of a membrane-embedded dap tetramer, and that the second 
calcium binding event induces the tetramer’s deep insertion into the membrane, translocation of some 
tetramers to the inner leaflet, and subsequently octamer formation.8,21  
1.3.3 Other proposed action modes 
This section discusses alternative dap action modes, namely non-selective membrane permeabilization 
and dislodgement of membrane-associated proteins.3,6,17 Before proceeding it is important to highlight 
that both proposed action mechanisms include the theory that dap binds to PG in a calcium-dependent 
fashion and dap oligomer formation is essential for bactericidal activity.  
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Jung et al. (2004) observed leakage of the fluorescent dye calcein from PG containing liposomes upon 
treatment with calcium and dap. Based on this observation they came to the conclusion that membrane-
bound dap must bring about bacterial death by acting as detergent and permeabilizing  bacterial 
membranes  in a  non-selective fashion.6 The findings of Jung et al. (2004) should be taken with a grain 
of salt as they may not be biologically relevant; firstly, the study used non-physiologically dap 
concentrations – studies show that dap’s free concentration in blood is 3µM, and Jung et al. (2004) 
utilized 10 µM.22–24 Secondly, these experiments were not conducted on bacteria; when similar 
experiment were conducted with calcein encapsulating bacteria no dye leakage was observed upon 
treatment with dap (1.24 µM) and calcium (1.22 mM).25  
Müller et al. (2016) propose that on Bacillus subtilis cells and other bacteria dap achieves 
antimicrobial activity by the dislodgement of membrane-bound enzymes that are crucial in the 
biosynthesis of the cell membrane and cell wall. Through experiments with the lipophilic fluorescent 
dye laurdan, whose emission spectrum shifts with changes in membrane fluidity, it was observed that 
dap, likely due to its bulky nature, inserts into regions of increased membrane fluidity.3,26 They propose 
that dap’s bulky nature restricts lipid acyl motion, which alters lipid packing and rigidifies the 
membrane creating cracks; these cracks are consequently filled in by migration of other fluid. As dap 
oligomers translocate from the outer to inner leaflet this fluid lipid sequestration and crack-filling is 
further propagated, thereby, increasing the rigidity of the bulk membrane; consequently, causing the 
expulsion of membrane-associated proteins. The membrane-associating proteins leave the rigidified 
membrane because they require regions of increased membrane fluidity to adopt the correct 
conformation and carry out key cellular functions.3 The theory proposed by Müller et al. (2016) should 
also be taken with grain of salt because they did not correct for dap’s intrinsic fluorescence; laurdan 
and dap’s kyn-13 have overlapping excitation and emission wavelengths.17,26,27 Therefore, without 
correction for kyn-13 signal it is not possible to discern if the fluorescence changes being observed are 
caused by laurdan or dap; as shown for example in Section 2.3.1 Figure 2-2, the fluorescence intensity 
of kyn-13 in membranes is quite significant. Consequently Mueller’s fluorescence data is 
inconclusive.27 
1.4 The Antimicrobial Crisis and its consequences  
With the rising bacterial resistance to common antibiotics, it was decided that certain antimicrobial 
compounds would not see widespread use, but would rather be prescribed to patients only if all other 
treatments failed.28 As time progressed, the ineffectiveness of common antibiotics became quite acute, 
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necessitating the frequent prescription of these last resort antimicrobial compounds.28,29 The increased 
use of these last resort compounds provided bacteria with ample opportunity to develop resistance 
mechanisms, leading to the emergence so called ‘super bugs’, that is pathogenic bacteria whose 
infections cannot be treated by any antibiotics currently known to humanity.30 The existence of 
superbugs is a major public healthcare crisis requiring urgent resolution; one strategy is to invent novel 
antibiotics that can be used to combat bacterial resistance. One method of novel antibiotic discovery, 
that has been successful in the past, is the production of analogs based on existing antimicrobial 
compounds.31 
The creation of analogs requires finding a suitable parent compound; a viable parent molecule is an 
antibiotic that has good antimicrobial activity across a broad spectrum of bacteria, has little antibiotic 
resistance, and  a well understood action mode, and structure activity relationship (SAR).31 One such 
promising candidate molecule is dap; it is a potent-broad spectrum antibiotic for Gram-positive bacteria 
that  has few reported cases of clinical resistance, but as detailed previously its action mode is not well 
understood.1,3,32,33 Accordingly, gaining a better understanding of dap’s action mode is of paramount 
importance in order to facilitate successful analog design.  
1.4.1 Bacterial Resistance to Daptomycin 
Although bacterial resistance to dap is infrequent there are still cases of resistance reported in clinical 
literature. The mechanisms discussed below are quite interesting because they relate to work presented 
in this thesis; they both involve bacteria altering the composition of their cytoplasmic membrane to 
attain dap resistance.  
It has been observed that resistant strains of Staphylococcus strains have increased lysyl-PG content in 
their cytoplasmic membranes.29 The increase in lysyl-PG content has been attributed to upregulation of 
multiple peptide resistance factor (mprF), a transmembrane protein with 2 domains: the first domain is 
a tRNA aminoacyl transferase that converts PG to lysyl-PG, and the second domain is a flippase domain 
the flips lysyl-PG from the inner to the outer leaflet of the cytoplasmic membrane. 29,34 The exact 
mechanism by which increased lysyl-PG content imparts resistance to S. aureus cells is not firmly 
established, but there two current hypotheses: overproduction of lysyl-PG simply depletes  the amount 
of PG available for dap  to bind, or the cationic nature of lysyl-PG creates a sort of electrostatic shield 
around the membrane limiting dap’s ability to bind.29,35,36 Recent work by Khatib et al (2016) suggests 




The second mechanism of resistance involves increased concentrations of CL in bacterial cytoplasmic 
membranes. The mechanism by which CL imparts resistance, similarly to lysyl-PG, is not established 
and there two hypotheses: the first involves CL’s ability to restrict dap to the outer membrane leaflet, 
thereby disrupting cation-selective pore formation (see section 1. 3.1 for a more detailed explanation), 
and the second, less investigated, theory suggests that because CL is made by conjoining two PG 
molecules its production diminishes the PG available for binding.20  
1.5 Research Questions 
This thesis aimed to deepen the understanding of dap’s action mode by investigating two specific 
research questions: 
1. Section 1.3. 2 details various proposed action modes of dap, which were at least in part based on 
different effects observed on model membranes. While these model membranes typically shared 
the same phospholipid head groups, they differed with respect to the acyl tails.3,6,17,32 Therefore, 
it is important to determine whether dap’s action mode is affected by membrane phospholipid 
acyl tail composition. 
2. As noted above, there is consensus that dap’s effect involves the formation of oligomers in the 
cytoplasmic membrane. Elucidating the structure of these oligomers at high resolution would be 
important for better understanding dap’s action mechanism and structure-activity relationships; 
however, so far, no suitable membrane model has been found that would permit the study of the 
dap oligomer by NMR.37–39 This work investigates the suitability of styrene-maleic acid lipid co-
polymers stabilized lipid nanodiscs, a previously untested membrane mimetic system, to 
determine dap’s membrane-bound oligomeric structure by solution-state nuclear magnetic 
resonance. 




Chapter 2            
                           






Abstract: It has been reported that dap brings about its antimicrobial effect by permeabilizing and 
depolarizing bacterial cell membranes in a cation-selective fashion. Recent findings on model 
membrane systems suggest that such is not the case consequently allowing for the proposition of 
alternative action modes; alternative action mechanisms suggest that dap permeabilization is either non-
selective or does not occur at all. While designing the model membranes, for the alternative studies, 
experimenters considered the effects of lipid headgroups on dap’s action mode but assumed that lipid 
acyl tails had a negligible effect on dap activity.  In this chapter, this assumption is shown to be false. 
Various model membranes were studied that differed with respect to their lipid acyl tails but retained 
the same head group composition. It is shown that that on membranes composed of equal parts PG and 
phosphatidylcholine (PC), dimyristoyl lipids support membrane permeabilization, whereas dioleoyl 
and palmitoleyl lipids do not, even though daptomycin does bind to and from oligomers on all 
membrane types. These observations help reconcile some of the discrepant findings in the literature 
about dap’s action mode. 
                                                   
2 The work presented in this chapter includes data published in “Daptomycin Pore Formation is Restricted by 
Lipid Acyl Chain Composition,” by Robert Taylor, David Beriashvili, Scott Taylor and Michael Palmer, 2017, 
ACS Infect. Dis., 3, 11, 797-801. 
 
Author Contributions: Dr. Robert Taylor synthesized NBD-Dap, ran the kynurenine membrane binding assay, 
and the pyranine pore forming assay (replicates of the pyranine pore forming assay were run by the author of this 
thesis). MICs on NBD-dap were conducted by both Dr. Robert Taylor and the author of this thesis. The 
translocation and subunit stoichiometry assays were conducted solely by the author of this thesis. The comparison 
of bacterial lipid acyl tails was done by the author of this thesis, Dr. Robert Taylor, and Dr. Michael Palmer. The 
text in this chapter was written solely by the author of this thesis with parts adapted from the manuscript where 




An in-depth review of the literature regarding dap’s action mode suggests that the divergent findings 
have been obtained on model membranes that had similar head group composition, but different lipid 
acyl tails; specifically: 
• cation-selective pore formation was observed on LUVs composed of equal parts DMPC: 
DMPG.17 
• non-selective membrane permeabilization was inferred from observations made on LUVs 
composed of equal parts POPC: POPG.6  
• an additional proposed mechanism, which was not discussed in Chapter 1 because it was later 
disavowed by its authors, suggesting that dap oligomers extract membrane lipids, was inferred 
from results obtained on giant unilamellar vesicles (GUVs) composed of 7:3 DOPC: 
DOPG.32,40  
To establish whether the variation in acyl tails could indeed account for the different findings it was 
decided to assay LUVs, composed of equal parts PC: PG with varying acyl tails, for dap-induced cation-
selective permeabilization by fluorescence spectroscopy. A chemically defined membrane system was 
used because the different proposed action modes were characterized on model membrane systems 
composed of synthetic lipids, and additionally such systems afford total control over all experimental 
parameters, whereas an in vivo system does not.  
2.2 Methods and Materials   
Some sections of the materials and methods presented below are taken directly from the manuscript: 
Robert Taylor, David Beriashvili, Scott Taylor and Michael Palmer, 2017, ACS Infect. Dis., 3, 11, 797-
801.  
2.2.1 Synthesis of 7-nitro2,1,3-benzoxadiazol (NBD)-labeled daptomycin 
7-nitro2,1,3-benzoxadiazol dap (NBD-dap) was prepared using a modification of the procedure 
described before1. Daptomycin (79.4 mg, 1.0 equiv.; generously provided by Jared Silverman, formerly 
of Cubist, Inc.) was dissolved in water (milli-Q, 4 mL) into a dual-opening 50 mL round bottom flask. 
Sodium bicarbonate (NaHCO3, 12.3 mg) was added and both were stirred and brought to 55°C in an 
oil bath. A solution of NBD-Cl (10.75 mg, 1.1 equiv.) in methanol (HPLC grade, 4 mL) was added 
dropwise over 10 min. The mixture was stirred at 55oC for 1 hour under reflux. After the 1 hour was 
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reached, the reaction was terminated by adding 1 M HCl to a pH of ≈2-3. The reaction mixture was 
then evaporated to dryness and lyophilised. Analytic RP-HPLC of the mixture showed two major peaks, 
corresponding to native daptomycin (tr = 26 min) and NBD-daptomycin (tr = 40 min), respectively. 
The two products were separated on a semi-preparative column (Higgins Clipeus, C-18, 10 μm, with a 
linear gradient of 65% H2O (0.1% TFA)/35% acetonitrile to 55% H2O (0.1% TFA)/45% acetonitrile, 
over 50 minutes. The NBD-daptomycin fractions were collected and concentrated to dryness. This gave 
pure NBD-daptomycin, a yellow powder, after lyophilisation (8.81 mg, 10.1 % yield). The analytical 
RP-HPLC chromatogram (Higgins Clipeus analytical C-18 column, 5 μm, linear gradient of 65% H2O 
(0.1% TFA)/35% acetonitrile to 55% H2O (0.1% TFA)/45% acetonitrile (50 minutes) of the pure NBD-
daptomycin showed one peak with a tr = 41 min (see Figure 1 in Appendix A). The high-resolution 
mass spectrometry showed three peaks that are accounted for by a single molecular species (see Figure 
2 in Appendix A). 
2.2.2 Antibacterial activity assay 
Daptomycin and NBD-dap were tested against Bacillus subtilis ATCC 1046 at a concentration of 5 mM 
CaCl2. Each antibiotic was tested three times in duplicate; growth and sterility controls were run in 
parallel. The procedure used was as described before.10 The results were exactly as before.9  
2.2.3 Preparation of LUVs  
All lipids used to make liposomes were acquired from Avanti Polar Lipids (Alabaster, Alabama). Lipids 
included 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-
phospho-(1'-rac-glycerol) (sodium salt; DMPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt; POPG), 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC), and dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) 
(sodium salt; DOPG). LUVs were prepared as described before.9 Briefly, the requisite amounts of lipids 
– equimolar mixtures of PC and PG were used in each case – dissolved in chloroform/methanol (3:1) 
and dried under N2 in a round-bottom flask. After removal of chloroform, the lipid film was 
resuspended in the appropriate buffer, and the resulting lipid suspension extruded repeatedly through a 
100 nm polycarbonate filter. Liposomes were used at a final total concentration of 250 μM total lipid 
in the various assays unless stated otherwise. 
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2.2.4 Monitoring daptomycin-membrane interactions by kynurenine fluorescence 
The assay was conducted as follows: DMPC/DMPG, DOPC/DOPG or POPC/POPG liposomes were 
mixed with daptomycin (3 μM) and calcium chloride (0 to 100 mM final concentration, as stated in the 
Results section) in HEPES-buffered saline (20 mM HEPES, 150 mM NaCl, pH 7.4). Each sample was 
incubated for 3 minutes. Excitation spectra (emission wavelength: 445 nm) and emission spectra 
(excitation wavelength: 365 nm) were acquired on a PTI QuantaMaster 4 instrument. All trials were 
run in triplicates at 37ºC. 
2.2.4.1 Using kynurenine signal to monitor daptomycin’s interaction with membranes 
Assaying dap-membrane interactions by kyn-13 fluorescence was first done by Lakey et al. (1988), 
who  observed that kyn is an intrinsic polarity-sensitive fluorophore; as kyn enters further into a 
hydrophobic environment, like a membrane bilayer, its emission signal  increases and blue-shifts from 
465 nm to 445 nm.27  Consequently, through monitoring kyn’s  signal intensity at 445 nm it is possible 
to observe dap’s insertion into the bilayer as a function of calcium concentration.27 
2.2.5 Daptomycin membrane permeabilization monitored by pyranine fluorescence  
The assay was conducted as follows: DMPC/DMPG, DOPC/DOPG or POPC/POPG liposomes were 
prepared in 5 mM MES, 5 mM Tricine, 5 mM NaCl, 250 mM sucrose (MTS), pH 6.0 with 1 mM 
pyranine (Sigma-Aldrich). The resulting pyranine-containing LUVs were passed through a size 
exclusion column (Bio-Rad P-6DG, Bio-Rad, Richmond, CA, USA) using MTS pH 6.0 without 
pyranine to remove the excess non-entrapped dye. The size exclusion resin was degassed, and the 
column poured 1 hour before passing the sample down the column. Daptomycin (2 μM), the proton 
carrier carbonyl cyanide m-chlorophenyl hydrazone (CCCP, 5 nM), and calcium chloride 
(concentrations as stated in Results) were added into MTS buffer with 100 mM NaCl and at pH 8.0. At 
time 0, pyranine-loaded LUVs were added to a final concentration of 250 μM total lipid. Fluorescence 
(excitation S3 wavelength, 460 nm; emission wavelength, 510 nm) was monitored for 300 s. Triton 
X100 (Biorad, Richmond, CA, USA) (0.1% final concentration) was then added to solubilize the LUVs. 
The fluorescence intensity after Triton X-100 solubilization was used to normalize the entire curve. All 
experiments were run at 30ºC.  
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2.2.5.1 History and rationale of the pyranine assay   
The feasibility of using pyranine to detect antimicrobial peptide induced cation-selective 
permeabilization of membranes was first demonstrated by Clement et al. (1981).41 The assay was later 
adapted by Zhang et al. (2014) to show that dap oligomers form cation-selective pores. 
 
Figure 2-1. Pyranine-based pore formation assay. Panel A and B show that treating pyranine containing 
LUVs with CCCP or dap alone will not result in pyranine signal change as the transport of cations or 
protons will not be electroneutral. Panel C shows that treatment of LUVs with both CCCP and dap will 
cause electroneutral cation-proton exchange, and thus cause pyranine to emit as strong signal at 510 






Briefly, pyranine is a poly-anionic fluorescent dye that is excited at 460 nm. Its emission at 510 nm is 
pH-dependent; at pH <7 pyranine has a low signal intensity at 510 nm because its hydroxy group is 
protonated and is not a good donor of electron density into the conjugated system. At pH >7 the hydroxy 
becomes deprotonated forming an oxyanion that readily donates electron density into the conjugated 
cyclic system giving rise to a strong signal at 510 nm.41  
The rationale behind the assay is as follows: the assay couples, by way of the membrane potential, the 
transport of salt cations to the counter-transport of protons, which is detected by pyranine fluorescence.  
Practically, this is achieved as follows: pyranine is dissolved in a pH 6 low salt buffer and encapsulated 
into LUVs via the extrusion method. The extruded solution is passed through a size exclusion column 
to separate the pyranine containing LUVs from the non-encapsulated pyranine. The LUVs are then 
added to a cuvette, which contains a high salt, pH 8, and sucrose rich buffer (external buffer). A change 
in pyranine’s signal requires increasing intra-LUV pH by exchanging extra-LUV cations for intra-LUV 
protons. This is done by treating the pyranine-containing LUVs with both dap and the proton ionophore 
CCCP. The presence of both dap and CCCP (Figure 2-1 Panels A,B, and C) is required because the 
exchange of cations can only occur if the process is electroneutral.41,42     
2.2.6 Daptomycin membrane translocation assay  
This was adapted from Zhang et al. (2014).20 LUVs composed of phospholipids with varying acyl tails 
were treated with 1µM 2:1 NBD-dap: dap and 25 mM calcium containing HEPES-buffered saline (20 
mM HEPES, 150 mM NaCl, pH 7.4). After a 4-minute period of incubation to allow dap to bind to the 
membranes 1 mM dithionite (Sigma-Aldrich) was added to the mixture. Data collection was begun 50 
seconds before this addition to establish the unquenched base line. The NBD signal was recorded for 
400 seconds, after which Triton X-100 (Biorad, Richmond, CA, USA) (0.1% final concentration) was 
added to solubilize the LUVs and signal recorded for an additional 60 seconds. The curve was 
normalized to the average signal intensity before addition of dithionite (from 0-50 seconds). The course 
spectra (excitation wavelength: 465 nm; emission wavelength, 530 nm) were acquired on a PTI 
QuantaMaster 4 instrument. The data presented are the average of 3 independent experiments 
conducted at 37ºC. 
The experiments with 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) (ammonium salt)  (NBD-PE), bought from Avanti Polar Lipids (Alabaster, 
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Alabama),  (Figures 3 and 4 in Appendix) were conducted exactly as above except there was no use of 
NBD-dap or dap and the LUVs consisted of .5% mol/mol NBD-PE and equal parts PC: PG.  
Note: it was noticed that there is considerable batch to- batch variation in the activity of dithionite; the 
batch that was used at 1 mM had been freshly purchased. When used at concentrations greater than 3-
4 mM, this batch caused more extensive quenching of NBD-dap. This may be related to the introduction 
of sulfuric acid that forms through spontaneous chemical decay,43 but the possibly was not 
systematically examined. The assay is also affected by the calcium concentration; less experimental 
variation occurs at 25 mM than at lower concentrations. A 1:2 ratio of NBD-dap to dap is required to 
mitigate NBD fluorescence self-quenching.8,9,18 The data presented is the average with standard 
deviations of 3 independent experiments conducted at 37ºC.  
2.2.7 Daptomycin oligomer subunit stoichiometry  
Determination of dap oligomer subunit stoichiometry was conducted according to the methodology set 
out by Muraih et al.18 Briefly, LUVs, made as described above, were treated with premixed ratios of 
dap: NBD-dap (4:1, 6:1, 8:1, 10:1) (final concentration of 10 µM) and 5 mM calcium. This resulting 
mixture was incubated for 3 minutes and a fluorescence emission spectrum recorded. After the 
measurement, an additional 4 µM dap was added to the sample. After 3 more minutes of incubation 
another fluorescence emission spectrum was recorded. The emission spectra (excitation wavelength: 
365 nm; emission 400-600 nm) were acquired on a PTI QuantaMaster 4 instrument. The data presented 
is the average with standard deviations of 8 independent experiments conducted at 37ºC.  
2.2.7.1 Daptmycin oligomer subunit stoichiometry assay rationale and analysis.  
The rationale of this assay is to determine the subunit stoichiometry of dap oligomers by comparing the 
kynurenine signal from oligomers containing dap only to that of hybrid oligomers formed from 
mixtures of native dap and NBD-dap. The approach utilizes the fluorescence resonance energy transfer 
(FRET) that occurs, at an extremely short distance, between kynurenine and NBD.  
The method is based on the following assumptions:  
1. All oligomers contain the same number of subunits. 
2. The formation of dap oligomers goes to completion on the time-scale of the experiment  
3. The pre-mixture of NBD-dap and dap forms oligomers stochastically without segregation  
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4. Mixed oligomers, those composed of NBD-dap and dap, do not give rise to kynurenine 
emission signal because all kynurenine fluorescence within an oligomer is quenched by FRET 
to NBD 
5. Once oligomers form, they are stable on the time scale of the experiment.   
Based on assumptions 1 and 3, the fraction of native dap molecules (D) contained within native only 





where d is the fraction of unlabeled dap added to the NBD-dap, and dn is the fraction of native dap only 
containing oligomers. Because it is impossible to determine dn directly assumption 4 becomes vital. 
Assumption 4 states that all the measured kynurenine signal comes from oligomers containing native 
dap only and equates to the relative measured kynurenine fluorescence Fr; consequently, D could be 
directly determined from Fr if FRET is occurring only within oligomers. However, because FRET also 
occurs between adjacent oligomers a correction is required. To correct for the FRET between 
oligomers, a second sample of unlabeled dap is added, and it is assumed that the known quantity of 
donor-only oligomers formed from this sample is quenched by FRET between oligomers to the same 












where d1 and d2 are the molar amounts of native dap  in the premix and the second addition, I0, I1, and 
I2 are the signal intensities at 445 nm for a LUV blank, after the initial 3 minute incubation, and 3 
minutes after the second dap addition, and V1 and V2 are the sample volumes before and after the 
addition. Overall, it is then possible to replace D with Fr and then calculate the subunit stoichiometry n 
from the equation below:  




2.3.1 Daptomycin’s interactions with membranes composed either of equal parts 
DMPC/PG, POPC/PG, or DOPC/PG  
Before conducting the pyranine-based pore forming assay, it was imperative to establish whether dap’s 
ability to interact with membranes is affected by variation in phospholipid acyl tails. To this end, a 
mixture containing 250 µM LUVs, composed of equal parts either DMPC: DMPG, POPC: POPG, or 
DOPC: DOPG, and 3 µM dap was titrated with calcium. After each calcium addition and 3-minute 
incubation dap’s kyn-13 emission spectrum (excitation: 365 nm; emission 400-600 nm) was acquired. 
As mentioned in section 2.2.4.1, kynurenine’s emission signal is extremely polarity sensitive.27 
Therefore, as calcium concentration increases kyn inserts into the hydrophobic membrane interior, its 
emission signal concomitantly blue-shifts, from 465 nm to 445 nm, and becomes more intense.27 
 
Figure 2-2. Daptomycin’s interaction with LUVs composed of a conserved phospholipid headgroup 
composition of equal parts PC and PG and varying phospholipid acyl tails. Dap interacts with all 
membrane types at physiological concentrations of calcium. Dap does bind more avidly to membranes 
containing phospholipids with longer and unsaturated phospholipid acyl tails.  
 
The saturation of kyn signal at 1 mM calcium for all membrane types suggests that dap readily interacts 
with all membranes at physiological calcium concentrations (1.25 mM). It is noteworthy that less 




2.3.2 Cation-selective permeabilization of LUVs with variable phospholipid acyl tails.  
Permeabilization by dap at low micromolar concentrations was observed or not observed on membranes 
with different acyl compositions, but also using different experimental techniques.3,6,32,40 In this work, 
dap permeabilization was studied by using the same assay, but with membrane composed of different 
acyl tails.  
 
Figure 2-3. Daptomycin induced cation-selective pore formation on LUVs composed of phospholipids 
with conserved headgroup composition but variable fatty acid tail composition. 250 µM of either 
DMPC: DMPG, POPC: POPG, or DOPC: DOPG LUVs encapsulating 1 mM pyranine were used in 
the assay.  
 
The data show that dap readily permeabilizes DMPC: DMPG LUVs but not POPC: POPG and DOPC: 
DOPG LUVs. Considering that the lipid headgroup composition was conserved amongst experiments 
it is possible to conclude that phospholipids with increased acyl tail length (>14 carbons) with or 
without unsaturation inhibit dap cation-selective permeabilization. 
2.3.3 Daptomycin translocation across membranes composed of inhibitory 
phospholipid acyl tails 
Zhang et al. (2014) observed that membranes containing CL are not permeabilized by dap.20 Zhang et 
al. (2014) found that dap is not able to permeabilize CL containing membranes because on these 
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membranes almost all the dap is sequestered to the outer membrane leaflet. In contrast, LUVs which 
are readily permeabilized, those composed of equal parts DMPC: DMPG, have equal distribution of 
dap across the membrane leaflets.20 Further experiments by Zhang et al. (2014) found that on CL 
containing membranes dap oligomers were composed of 4 dap molecules, whereas on DMPC: DMPG 
LUVs dap oligomers consisted of 8 dap molecules. Consequently, Zhang et al. (2014) hypothesized 
that cation-selective pore formation by dap requires the formation of an octameric oligomer which is 
composed of two conjoined tetramers located on opposing leaflets.20  Based on Zhang et al. (2014) 
findings it was of interest to determine whether the lack of pore formation observed on POPC: POPG 
and DOPG: DOPC liposomes occurred via a similar mechanism.  
To determine dap translocation across membrane leaflets the dithionite/NBD fluorescence quenching 
assay was used. LUVs containing different phospholipid acyl compositions were treated with a premix 
of NBD-dap, dap and calcium. After a period of incubation to allow dap-membrane binding, dithionite 
was added to the mixture. Dithionite instantaneously reduces NBD that resides on the outer membrane 
leaflet and quenches its fluorescence.   
Figure 2-4. Daptomycin translocation across LUVs composed of phospholipids with acyl tails 
permissive and restrictive to dap cation-selective permeabilization. To make sure that dithionite could 
not cross the LUV membranes via dap’s pore NBD-PE experiments were run; this data can be found in 
Appendix A - Figures 3 and 4.  
 
Upon addition of dithionite to DMPC: DMPG liposomes the NBD signal instantaneously drops to 48 
± 6%, indicating that approximately half of all labeled daptomycin is located on the outer leaflet. The 
slow drop from 48% towards the baseline is due to transient flipping of dap between membrane leaflets. 
This result closely resembles that previously reported by Zhang et al. (2014), who reported that dap is 
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equally distributed between membrane leaflets. In contrast, on POPC: POPG and DOPC: DOPG 
liposomes the signal upon dithionite addition drops to 35 ± 1% and 31 ± 3% respectively. Therefore, 
on restrictive membranes roughly 70% of dap is located on the outer membrane leaflet. Unlike 
membranes which contain CL, which restricts dap to the outer leaflet, membranes composed of POPC: 
POPG or DOPC: DOPG allow for partially dap translocation.  
2.3.4 Daptomycin oligomer subunit stoichiometry on POPC: POPG and DOPC: DOPG 
liposomes 
Since dap is able to partially translocate across POPC: POPG and DOPC: DOPG membranes, it was of 
interest to see if the translocation was enough to facilitate the formation of octameric dap oligomers. 
The subunit stoichiometry was determined on DMPC: DMPG, POPC: POPG and DOPC: DOPG by a 
FRET-based assay developed by Muraih et al. (2012).18  
Figure 2-5. Daptomycin oligomer subunit stoichiometry on POPC: POPG and DOPC: DOPG 
liposomes. The subunit stoichiometry on DMPC: DMPG liposomes was 6.5 ± 0.67, on POPC: POPG 
liposomes 4.7 ± 0.7, and on DOPC: DOPG liposomes 3.6 ± 0.9.  
 
Even though dap is able to partially translocate across the dap permeabilization-resistant membranes 
(those containing POPC: POPG and DOPC: DOPG) the octameric oligomer does not form; rather 
formation of a tetrameric oligomer is observed. It is important to point out the subunit stoichiometry 
on DMPC: DMPG is lower than 8 subunits; this is likely due to incomplete FRET within oligomers. 
2.4 Discussion 
The kynurenine-based membrane interaction assay shows that dap interacts with all three LUV types 

































maybe because these lipids have unsaturated lipid acyl tails.44 Lipids with unsaturated acyl tails tend to 
be less tightly packed in a bilayer environment possibly making it easier for dap to insert.44 For DM 
lipids more calcium may be required to overcome the steric hinderance that arises from tighter lipid 
packing. 
Cation-selective pore formation is observed on liposomes composed of phospholipids with myristoyl 
acyl tails and not with palmitoyl and oleoyl acyl tails. Considering that the phospholipid headgroup 
composition was conserved amongst the LUVs it is possible to conclude that phospholipids with 
increased acyl tail length and/or unsaturation inhibit dap’s ability to permeabilize those LUVs.  
Palmitoyl and oleoyl lipids restrict dap pore formation by inhibiting octameric oligomer formation. The 
data suggest that dap binds to the inhibitory membranes, and forms tetramers that freely equilibrate 
between membrane leaflets. These tetrameric oligomers are not able to align, and form the octamer 
required for pore formation. Consequently the unaligned tetramers are able to continue equilibrating 
between leaflets with a preference to the outer leaflet ; experiments by Pogliano et al. (2012) show that 
dap has preference for membrane regions exhibiting curvature – whether it is negative or positive was 
not empirically determined.5 It is likely that on DMPC: DMPG membranes dap is equally distributed 
between the leaflets because octamer formation is energetically favorable.       
It has been proposed that dap brings about its antimicrobial effect by dislodgement of membrane-
associated biosynthetic enzymes. The authors proposing this mechanism initially began their studies 
by attempting to determine whether Bacillus subtilis membranes are permeabilized by dap in a cation-
selective fashion; they did not observe dap permeabilization of Bacillus subtilis cells  
(personal communication from the authors of this paper indicates that pore-forming experiments were 
done in the absence of calcium; thus, casting doubt on the validity of the results).3  Based on the results 
from this study, it is quite possible that they did not observe cation-selective permeabilization because 
the phospholipid acyl tail composition of Bacillus subtilis cells is different from Staphylococcus aureus 
cells, on which cation-selective permeabilization has been observed, and is inhibitory to dap membrane 
permeabilization.12,45–47 It is noteworthy that the proposed mechanism of membrane-protein 
dislodgement assumes dap’s ability to translocate across membranes.3 Dap’s ability to partially 
translocate across membranes resistant to permeabilization suggests that on bacteria resistant to dap 
pore formation the  antimicrobial effect maybe brought about by dap translocation.   
Lastly, it is important to note that the membranes used in this study are quite different in composition 
from membranes found in Gram-positive bacteria. For example, PC is not commonly found in Gram-
 
 22 
positive bacteria, but is used because of significant precedence.12,46 Also, liposomes lack membrane 
asymmetry, membrane proteins, and glycol-phospholipids all of which may affect dap’s action mode 
in yet unknown ways. Additionally, the lipids acyl tails used in this study are not fully representative 
of those found in bacteria; Figure 5 in Appendix A shows that vast variation in lipid acyl tails of Gram-
positive bacteria clinically treated by dap. It is important to note that the goal of this work was not to 
recreate the most life-like mimetic of a bacterial cytoplasmic membrane, but to reconcile discrepancies 
between previous studies on model membranes. Therefore, the choice of lipids was dictated by the 
lipids used in previous studies. Beyond the observation that lipid acyl chains can modify the activity of 
daptomycin, no specific inferences should be drawn from this work regarding the susceptibility of 




Chapter 3            
              
Mechanistic studies on the effect of membrane lipid acyl chain 





Abstract: Daptomycin permeabilization of membranes is dependent on their phospholipid acyl 
composition. In this study, liposomes were used to study the effects of phospholipids with various acyl 
tails on dap activity. Through the course of this work the following observations were made: oleoyl 
acyl tails inhibit dap’s pore formation regardless of the headgroup moiety they are ligated to. This 
inhibition occurs even at low membrane concentrations of oleoyl lipids (10% DOPC). The inhibitory 
effect of acyl tails is correlated with their length rather than with their degree of unsaturation. 
Additionally, it was observed that dap permeabilization occurs only when octameric oligomers are 
formed, corroborating that the octamer constitutes the functional cationic pore. Overall, the results in 
this study indicate that acyl tails that inhibit daptomycin pore formation do so by disrupting the 
                                                   
3 The data presented in this chapter has been published in “Mechanistic studies on the effect of membrane lipid 
acyl chain composition on daptomycin pore formation,” David Beriashvili*, Robert Taylor*, Braden Kralt, 
Nooran Abu Mazen, Scott D. Taylor, and Michael Palmer, 2018 Chemistry and Physics of Lipids., 216, 73-79. 
*These authors contributed equally to this work. 
 
Author Contributions: Braden Kralt and Nooran Abu Mazen synthesized and purified NBD-dap. The author of 
this thesis ran MICs for NBD-dap and the anteiso C12-dap analog. The anteiso C12-dap analog was synthesized 
by Braden Kralt. Dr. Robert Taylor ran MICs on C14-dap. Robert Taylor ran 4 of 6 replicates for the pore forming 
assays presented in Figure 1 and the author of this thesis ran the remaining 2 replicates - except for the 5% DOPC 
liposomes which had all replicates run by Dr. Robert Taylor. The kynurenine fluorescence-based assay for 
monitoring membrane-dap interaction was run by the author of this thesis. All the subunit stoichiometry and 
translocation assays presented in this chapter and the manuscript were acquired by the author of this thesis. All 
fluorescence anisotropy assays for determination of membrane fluidity were run by the author of this thesis with 
exception of the 10% TMCL assay which was run by Dr. Robert Taylor. The pore formation assays on 10% 
cardiolipin LUVs, and with C14-Dap were run by Dr. Robert Taylor. The pore formation assays on dap-treateded 
10% DPDPC LUVs, on anetiso C12 dap-treated DOPC: DOPG LUVs, 20% TMCL were run by the author of this 
thesis. The text in this chapter was written solely by the author of this thesis with parts adapted from the 
manuscript where indicated.   
 
 24 
alignment of tetramers across membrane leaflets, which on susceptible membranes gives rise to the 
octameric functional pore. 
3.1  Introduction  
In the previous chapter, it was observed that phospholipids with acyl tails longer than 14 carbons and 
a cis-unsaturation inhibit dap’s ability to create cation-selective pores.13 The experimental data suggest 
that these lipid acyl tails inhibit dap pore formation by halting oligomerization at the stage of the 
tetramer. The inability to form octameric oligomers likely causes the uneven distribution of dap across 
membrane leaflets 5,13 The work conducted in this chapter builds on findings from the previous one by 
answering the following questions: 
• In the previous chapter, the acyl tails which caused the inhibitory effect were attached to both 
PC and PG. Since PG is specifically required for dap binding, do the inhibitory acyl chains 
have to be part of this lipid?9 
• In chapter 2 it was confirmed that the only model membranes susceptible to dap 
permeabilization were those that contained dimyristoyl lipids only. The inhibitory acyl tails 
differ from myristic acid by both greater length and unsaturation; Consequently, can the 
inhibitory effect be attributed to either of these properties? 
• Lastly, previous work by researchers at Eli Lily implicates dap’s acyl tail moiety as a key 
modulator of its activity; dap analogues with longer or branched acyl tails had higher 
antimicrobial activity.2 Can such analogues also restore permeabilization on membranes that 
are impervious to daptomycin? 
3.2 Materials and Methods 
Some sections of the materials and methods presented below are taken directly from the manuscript: 
David Beriashvili*, Robert Taylor*, Braden Kralt, Nooran Abu Mazen, Scott D. Taylor, and Michael 
Palmer, 2018 Chemistry and Physics of Lipids., 216, 73-79. David Beriashvili, Dr. Robert Taylor, 
Braden Kralt, Dr. Scott Taylor, and Dr. Michael Palmer contributed to the writing of the materials and 
method section. *These authors contributed equally to this work 
3.2.1 Synthesis of 7-nitro2,1,3-benzoxadiazol (NBD)-labeled daptomycin 
The synthesis was carried out according to Muraih et al.(2011) with minor modifications, as follows: 
Daptomycin (40.5 mg, 25 µmol), which was generously provided by Jared Silverman, formerly of 
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Cubist, Inc., was dissolved in a buffer (20.5 mL) containing 50 mM sodium borate and 20 mM EDTA 
at pH 8. To this was added a solution of 4-chloro-7-nitrobenzofurazan (NBD-Cl, 67.8 mg, 13.6 eq) in 
acetonitrile (13.6 mL) and the reaction was stirred at 55°C for 3 hours. Following the reaction time, the 
solution was brought to 0°C in an ice bath and quenched with the addition of 200 µL of acetic acid. 
The mixture was then purified on a Proto 200 C18 10 µm analytical column with an isocratic mobile 
phase of 33% acetonitrile, 67% 20 mM ammonium acetate buffered at pH 5.5, over 50 minutes. 
Fractions were collected and concentrated to dryness. The residue was suspended in Milli-Q water and 
lyophilized, giving pure NBD-daptomycin (4.4 mg, 9.8 %). The analytical RP-HPLC chromatogram 
(Proto 200 C18 10 µm) linear gradient of 31:69 acetonitrile / 20 mM ammonium acetate buffer (pH 
5.5) to 38:62 acetonitrile / 20 mM ammonium acetate buffer (pH 5.5) over 40 minutes of the pure NBD-
daptomycin showed one peak with a tr = 27 minutes (See Figure below). The single peak was collected 
and analyzed by ESI-MS. The molecular weight of protonated NBD-daptomycin (sum formula: 
C78H102N20O29) is 1783.719; the experimental value as determined by mass spectrometry is 
1783.721. Typical HPLC and MS results are shown in Figures 1 and 2 in Appendix B. The MIC of the 
purified compound was 1.25 µg/ml (native daptomycin: 0.75 µg/ml). 
3.2.2  Synthesis and characterization of C14-daptomycin 
The steps for this synthesis were done using the method by Gantner et al. (2014).48 Myristic acid (1.31 
mmol) and N, N’-dicyclohexylcarbodimide (1.57 mmol) were added to a round bottom flask in THF 
(2.62 mL) and stirred at room temperature for 10 minutes. N-hydroxysuccinimide (1.57 mmol in 1.41 
mL THF) was added and the reaction was stirred for 22.5 hours at room temperature. The solvent was 
removed under reduced pressure, and dry-loaded onto a silica gel column. The product was eluted 
using 50:1 chloroform:methanol with an Rf =0.76. It was concentrated under reduced pressure and 
lyophilized to produce a white powder (221.33 mg, 51.76% yield). 1H NMR (300 MHz, CDCl3): δ2.83 
(s, 4H), 2.60 (t, J = 7.4 Hz, 2H), 1.74 (papp, J = 6.9 Hz, 2H), 1.26 (m, 20H), 0.88 (t, J = 5.8 Hz, 3H). 
LRMS (ESI-MS) m/z: 326 (M+H+)+; HRMS (ESI-MS) calculated for C18H31N1O4 326.2461; found 
326.2359.  
To a solution of Boc-deacyl-daptomycin (15.6 mg, 10 µmol; generously provided by Cubist, Inc.) in 
dry DMF (0.5 ml) was added myristic acid succiminidyl ester (3 mg, 6 µmol, 0.6 eq.). Triethylamine 
(7 µL, 50 µmol, 5 eq.) was added and the mixture stirred for three days, at room temperature. After 
this, trifluoroacetic acid with 0.2% thioanisole (5 mL) was added and stirred at 0oC for 20 minutes, 
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under argon. Analytic RP-HPLC (Higgins Clipeus, C18 column, 10 µm) utilizing a mobile phase of 
0.1% trifluoroacetic acid with ultrapure water and an acetonitrile gradient from 10% to 90% over 60 
minutes showed that all of the Boc-deacyl-daptomycin was consumed and a single major peak was 
present (tr = 44 min) as well as a native Dap peak at tr = 19 min. The solvent was removed under 
reduced pressure and the residue dissolved in ultrapure water and lyophilized, resulting in a white 
powder (17.0 mg, 98% yield). The analytical RP-HPLC chromatogram (Higgins Clipeus, C18 column, 
10 µm) using a mobile phase of 0.1% trifluoroacetic acid with ultrapure water and an acetonitrile 
gradient from 10% to 90% over 60 minutes, gave pure C14-daptomycin showing one major peak with 
a tr = 17 min (Figure 5A). Mass spectrometry (ESI-MS) showed one singly charged peak with the 
expected molecular mass of 1676.8 (M + H+)+, as well as several accompanying most likely arising 
from 13C incorporation. The MIC of the purified compound was 0.5 µg/ml (native daptomycin: 0.75 
µg/ml). HPLC trance and mass spectrometry analysis of C14-dap can be found in Figure 3 and 4 in 
Appendix B respectively.  
3.2.3 Synthesis and characterization of ante-daptomycin 
Synthesis of 2,5-dioxopyrrolidin-1-yl 10-methyldodecanoate: To a 25 mL round-bottom flask was 
added 10-methyldodecanoic acid (25 mg, 0.116 mmol, 1 eq). To this was added a solution of NHS 
(19.8 mg, 0.172 mmol, 1.5 eq) in dry CH2Cl2 (5 mL) until dissolution. The reaction was cooled to 0 °C 
in an ice bath. To the chilled stirring solution was added EDC (37.0 mg, 0.193 mmol, 1.67 eq) and 
DMAP (1.4 mg, 0.012 mmol, 0.1 eq). The solution was stirred at 0 °C for 1 hr, after which the ice-bath 
was removed, and the mixture stirred for an additional 20 hours as monitored by TLC. Following the 
reaction time, the mixture was diluted with EtOAc (15 mL). The organic phase was washed with 0.1 
M HCl(aq) (1x 15 mL), then washed with Sat. NaHCO3 (1x 15 mL), and finally washed with brine (1x 
15 mL). The organic phase was dried off with Na2SO4, concentrated, and the residue was purified by 
column chromatography with a mobile phase of 1:1 EtOAc-hexane, to yield the desired product as a 
white solid (36 mg, quant). 1H-NMR (300 MHz, CDCl3) δ: 2.81 (4H, s), 2.58 (2H, t, J = 7.4 Hz), 1.72 
(2H, app. quint., J = 7.2 Hz), 1.38-1.04 (16H, m), 0.85-0.81 (6H, m). 13C- NMR (75 MHz, CDCl3) δ: 
172.1, 171.6, 39.5, 37.3, 33.8, 32.8, 32.4, 32.3, 32.0, 31.7, 29.0, 28.5, 27.4, 22.1, 14.3. HRMS (ESI+): 
m/z [M+H+]+ calculated for C17H29NO4: 312.21693, found 312.21668. 
Synthesis of ante C12-daptomycin: To a 7 mL glass vial was added Boc-Deacyl-Dap (10 mg, 6.4 
µmol, 1 eq). The vial was equipped with a stir bar, and dry DMF (200 µL) was added. To this was 
added triethylamine (9 µL, 0.065 mmol, 10 eq) and 2,5-dioxopyrrolidin-1-yl 10-methyldodecanoate 
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(2.9 mg, 9.6 µmol, 1.5 eq) and the suspension was stirred for 72 hours. The reaction was concentrated 
on a high-vacuum rotary evaporator and re-dissolved in water followed by lyophilization. Then, the 
crude product was stirred in a solution of TFA (1 mL) containing thioanisole (2% v/v) for 25 minutes 
in an ice-bath. The solution was concentrated in vacuo, and the residue re-dissolved in dry DMF, with 
the solvent being removed once more. The oily residue was dissolved in water and lyophilized before 
purification by preparative HPLC using a Clipeus C18 10 µm column employing a linear gradient of 
57:43 H2O (+0.1 % TFA) / acetonitrile to 54:46 H2O (+0.1 % TFA) / acetonitrile. Fractions containing 
the desired compound were pooled and concentrated, suspended in water and lyophilized to obtain the 
desired product as a white powder (9.6% yield). HRMS (ESI+): m/z [M+2H+]2+ calc’d for 
C75H107N17O26: 831.88593, found 831.88348.  The analytical HPLC trace of the purified compound and 
mass spectra can be found in Appendix B figures 5 and 6 respectively. 
3.2.4 Antibacterial activity assay 
The antimicrobial assay was completed as described in section 2.2.2. 1.25 mM CaCl2 was used in the 
studies. All MICs were identical those reported in literature.2  
3.2.5 Preparation of LUVs  
All the lipids used in this study were acquired from Avanti Polar Lipids (Alabaster, Alabama). Lipids 
include: 1,2-dimyristoyl-sn-glycero3-phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3phospho-
(1′-rac-glycerol) (sodium salt; DMPG), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), dioleoyl-
sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt; DOPG), 1′,3′-bis[1,2dimyristoyl-sn-glycero-3-
phospho]- sn-glycerol (sodium salt; TMCL), 1′,3′-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol 
(sodium salt; TOCL), 1,2-dipentadecanoyl-snglycero-3phosphocholine (DPDPC), and 1,2-
dimyristoleoyl-sn-glycero3-phosphocholine (DMPC-Δ9-Cis). The lipids were dissolved into 
chloroform and methanol (3:1) and were used without further purification. Liposomes were prepared 
via the extrusion method as described in section 2.2.3. Liposomes were used at a final total 
concentration of 250 μM total lipid in the various assays unless stated otherwise. 
3.2.6 Monitoring daptomycin-membrane interactions by kynurenine fluorescence 
The assay was conducted exactly like detailed in section 2.2.4.  
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3.2.7 Daptomycin membrane permeabilization monitored by pyranine fluorescence  
The assay was conducted as described in section 2.2.5 with the exception that 2 mM dithionite was 
used. The increase in dithionite was required because with time dithionite degrades.43 All experiments 
were run at 30 °C, except those shown in Figure 3-5 and 3-6 and , which were run at 37 °C. The results 
shown are the average of 6 independent experiments each. 
3.2.8 Daptomycin membrane translocation assay  
The assay was conducted exactly like detailed in section 2.2.6. In the experiments involving ionomycin, 
100 nM ionomycin (Millipore-Sigma), 3 µM (2:1) native: NBD daptomycin, and 25 mM CaCl2 were 
added to equimolar DOPC/DOPG liposomes and incubated for 15 minutes. In some experiments, 10 
nM of the proton carrier carbonyl cyanide m-chlorophenyl hydrazone (CCCP) were also included. 
These conditions were chosen after consulting Erdahl et al. (1994).49 
3.2.9 Daptomycin oligomer subunit stoichiometry  
The assay was conducted exactly like detailed in section 2.2.7. The sole deviation from the protocol 
discussed in section 2.2.7 concerns the “low daptomycin” sample in Figure 3-6, Panel D, in which 2 
µM rather than 10 µM of a mixture of native daptomycin and NBD-daptomycin (molar ratio, 2:1) were 
added to the liposomes in the first step, and 0.9 µM of native daptomycin was added in the second step 
to correct for inter-oligomer. All experiments we run at 37°C. 
3.2.10 Diphenylhexatriene fluorescence polarization membrane fluidity assay  
The phase transition temperatures of liposomes containing tetramyristoyl-cardiolipin (TMCL) or di-
pentadecanoyl-phosphatidylcholine (DPDPC) were determined using the diphenylhexatriene 
polarization assay introduced by Shinitzky et al. (1974).50 1,6-Diphenyl-1,3,5-hexatriene (DPH; 
Millipore-Sigma) dissolved in methanol was added to liposomes in a 1 mL cuvette to a final 
concentration of 10 μM, followed by incubation for 10 min. For fluorescence anisotropy measurements, 
DPH was excited at 350 nm and emission measured at 428 nm. Data were acquired on a PTI 




3.3.1 Daptomycin interaction with chimeric liposomes 
In the previous chapter, it was observed that dap binds to membranes composed of DO and PO lipid 
acyl tails at lower calcium concentrations than dimyristyl containing membranes. The avid binding was 
attributed to the looser packing of lipids within such membranes. The goal of this experiment was to 
determine whether the avid binding is caused by the oleoyl groups attached to the PC or PG headgroup; 
to test this dap’s kynurenine signal was used to monitor dap’s interaction with chimeric liposomes 
composed of either equal parts DOPC: DMPG or DMPC: DOPG. 
Figure 3-1. The effect of acyl tails on daptomycin binding to LUV membranes, measured by kynurenine 
fluorescence. The assay was conducted exactly a described in the previous chapter; samples contained 
3 µM dap and 250 µM lipids (equal parts PC and PG).  
 
Surprisingly, chimeric liposomes, those composed of equal parts DOPC: DMPG or DOPG: DMPC, 
require as much or more calcium for binding dap than observed with DMPC: DMPG liposomes. 
Overall, the data suggests that at physiological calcium concentrations dap interacts with all tested 
LUVs regardless of their lipid acyl tail composition. On liposomes containing mixtures of 
phospholipids, with bulky and non-bulky acyl tails, no preferential binding is observed. 
 
3.3.2 Whose acyl tails are responsible for inhibition of pore formation; PC, PG, or both? 
In section 2.3.2 it was reported that liposomes composed of equal parts DOPC: DOPG are not 
permeabilizated towards cations by dap. This raises the question whether oleoyl residues in either or 
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both of PC and PG are required for inhibition. To test this hypothesis, the pyranine-based pore forming 
assay was run on liposomes with the inhibitory oleoyl acyl tails attached to different headgroups.    
 
As evident from Figure 3-2, the pyranine-based pore formation assay yielded the same results as 
reported previously; DMPC: DMPG liposomes are permeabilized by dap in a cation-selective fashion 
whereas liposomes composed of equal parts DOPC:DOPG are not. Interestingly, dap pore formation is 
inhibited regardless of whether the acyl tail is attached to PC or PG and is inhibited when as little as 
10% DOPC is present in the membrane. The data suggests that the inhibition of dap pore formation by 
lipid acyl tails is not dependent on which lipid headgroup the inhibitory acyl tails is attached to, but 
inhibition simply occurs if that restrictive acyl tail is present in the membrane; it even occurs at 
concentrations as low as 10 mol%. 
Figure 3-2. Daptomycin permeabilization of liposomes composed of varying amounts of DOPC:PG 
and DMPC:PG. The forming assay was completed as detailed in the previous chapter. The fluorescence 
signal was normalized to the average signal intensity observed after addition of Triton X-100 at 300 
seconds.   
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3.3.3 Does inhibition of daptomycin pore-formation by 10% DOPC correlate with 
tetramer formation and consequently daptomycin sequestration?  
In the last chapter it was proposed that phospholipid acyl tails with more than 14 carbons and 
unsaturation inhibit dap pore formation by not allowing octamers to form. The inability to form 
octamers consequently leads to asymmetric distribution of dap between the membrane leaflets. The 
purpose of this work was to determine whether liposomes containing 10% DOPC, 40% DMPC, and 
50% DMPG inhibit pore formation via a similar mechanism, or whether they might permit formation 
of a complete yet functionally deficient octamer. Initially, the FRET-based stoichiometry assay was 
used to determine the number of dap molecules per dap oligomer formed on 10 mol% DOPC liposomes, 
and subsequently the dithionite-based translocation assay was run to determine dap membrane 
distribution.   
 
 
Figure 3-3. Translocation and subunit stoichiometry of daptomycin oligomers on 10% DOPC 
liposomes. The assays were conducted as detailed in the previous chapter. The DMPC: DMPG data 
were adapted from Zhang et al. (2014) .20 
 
Figure 3-3 suggests that 10% DOPC in a background of permissive lipids (DMPC:DMPG) inhibits dap 
cation-selective pore formation via the same mechanism as observed with pure DOPC:DOPG 
liposomes; on both types of inhibitory liposomes tetramers are formed,  and more than 50% of the NBD 
signal instantaneously disappears upon addition of dithionite. Overall, it seems that the phospholipids 
with increased acyl tail length and/or unsaturation do not allow for the formation of octameric dap 
oligomers, even if they constitute only 10% of the total lipid. The inability to form octameric oligomers 
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allows them to continue freely equilibrating between leaflets with a preference to the outer membrane 
leaflet.  
 
Further, it was considered that the distribution of dap across the two membrane leaflets might not have 
reached equilibrium at the time of the measurement. To test for this possibility, the translocation assay 
was repeated with dap-treated liposomes that were incubated for longer than 5 minutes (15 minutes- 
see Figure 3-4 DOPC: DOPG) before addition of dithionite. Regardless of pre-incubation time, roughly 
70% of the NBD signal disappeared upon dithionite addition suggesting that all samples, including 
those shown in Fig. 3-3, had indeed reached equilibrium. 
3.3.4 The effect of intraliposomal calcium on daptomycin translocation 
The asymmetrical distribution of dap on membranes containing phospholipids with acyl tails 
inhibitory to dap cation-selective pore formation could be due to the lack of intra-liposomal calcium. 
In all experiments with LUVs, calcium is added to the buffer only, but not contained inside the LUVs, 
because membrane extrusion of MLVs does not work its presence.  However, dap can transport calcium 
ions across membrane bilayers, which means that it will be present on both sides of permissive 
membranes.32,42 On the other hand, membranes containing acyl tails that inhibit dap permeabilization 
will likely not have calcium transported into their intraliposomal space. Consequently, it is possible 
that calcium stabilizes and retains daptomycin on the inner membrane leaflet on susceptible, but not on 
impervious membranes. Evaluating this hypothesis directly is very difficult because extrusion does not 
work well at high calcium concentrations. It is possible to use detergent-based methods to create 
calcium containing liposomes; the problem with these methods is that no matter how much time is spent 
removing the detergent, after liposome creation, some residue of detergent remains.51 Considering the 
sensitivity of dap to its membrane environment that is not a risk worth taking.3,13 Hence, it was decided 
to introduce calcium into the intraliposomal space by treating DOPC: DOPG liposomes with the 
calcium ionophore ionomycin.49 After a period of incubation with ionomycin, to allow for calcium 
influx, NBD-dap could be added to the calcium-loaded liposomes and translocation determined. 
Together with ionomycin, the proton ionophore CCCP was also added to facilitate compensation of the 
electrogenic calcium flux.49 It is expected that if calcium does play a role in dap’s distribution between 
membrane leaflets, then distribution of dap on DOPC: DOPG liposomes leaflets would become less 
asymmetrical.   
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As evident from Figure 3-4 the presence of intraliposomal calcium does not seem to change the 
distribution of dap on equal part DOPC: DOPG membranes. This suggests that the asymmetrical 




Figure 3-4. Effect of intra-liposomal calcium on daptomycin distribution on equal part DOPC: DOPG 
membranes. The assay utilized 250 µM DOPC: DOPG liposomes with or without the calcium 
ionophore ionomycin (100 nm) and/or CCCP (5nm).  Controls with ionomycin and CCCP alone yield 
results identical to those obtained on DOPC: DOPG LUVs. Dithionite was added 15 minutes after 
incubation with ionomycin or addition of dap.  
 
3.3.5 Is dap pore formation inhibition caused by lipid acyl tail unsaturation or increased 
acyl tail length? 
In previous experiments, dap pore formation was observed on membranes containing phospholipids 
with myristoyl acyl tails and not observed on membranes containing phospholipids with oleoyl acyl 
tails. The inhibitory oleoyl acyl tails are 4 carbons longer than myristoyl acyl tails and have a cis double 
bond. The purpose of the following set of experiments was to determine which of the two structural 
distinctions between myristoyl and oleoyl acyl tails causes the inhibitory effect. To test this the 
pyranine-based pore formation assay was conducted on liposomes composed of 10% di-pentadecanoyl-
phosphatidylcholine (DPDPC), 40% DMPC, and 50% DMPG or 10% 1,2-dimyristoleoyl-sn-glycero3-
phosphocholine (DMPC-Δ9-Cis), 40% DMPC, and 50% DMPG.    
Figure 3-5 shows that pyranine’s emission at 510 nm increases significantly more on liposomes 
containing 10% DMPC-Δ9-Cis than 10% DPDPC. This suggests the inhibition of dap cation-selective 
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pore formation is primarily caused by increased acyl tail length (see Figure 5 Appendix B for 
determination of DPDPC membrane phase transition temperature). The assay with DPDPC was run for 
60 seconds shorter than the other assays because the liposomes had poor stability with increasing time 
and the 300 second assay gave the most reproducible results. Although DPDPC is not a biologically 
relevant acyl tail, it was chosen instead of a biological relevant acyl tail because of its comparatively 
low phase transition temperature, which means that the LUVs should be in the fluid phase at the assay 
temperature.13,52 
 
Figure 3-5. Determining whether daptomycin pore formation inhibition is caused by acyl tail length or 
unsaturation. The pyranine-based pore formation assays were completed as detailed in chapter 2; the 
results shown in panel A were obtained on 10% DPDPC, 40% DMPC, and 50% DMPG LUVs, and the 
results in Panel B were obtained on 10% DMPC-Δ9-Cis, 40% DMPC, and 50% DMPG LUVs.  
 
3.3.6 Revisiting inhibition of dap pore formation on cardiolipin membranes 
Zhang et al. (2014) showed that membranes containing as little as 10% tetra-oleoyl cardiolipin (TOCL) 
inhibit dap pore formation by sequestering dap to the outer membrane leaflet.20 The issue with this 
finding is that Zhang et al. (2014) did not know, at the time, that oleoyl acyl tails are inhibitory to dap 
pore formation. Naturally, it is important to establish whether the inhibitory effect observed on 
membranes containing TOCL was caused the oleoyl lipid acyl tails or the CL headgroup moiety. To 
distinguish the contributions of the CL head group from that of the oleoyl side chains pyranine-based 
pore formation, FRET-basedsubunit stoichiometry, and dithionite/NBD-dap-based translocation assays 
were run on membranes containing 10% tetra-myristyl cardiolipin (TMCL), 40% DMPC, and 50% 




Before conducting any of the functional assays it was important to determine the phase transition 
temperature of TMCL containing membranes because model membrane composed purely of TMCL 
have a phase transition temperature of 47 ºC.52 The phase transition temperature of the membranes was 
determined by using the fluorescent probe DPH; due to its hydrophobic nature DPH inserts into 
membranes and as the membrane transitions from the gel phase to the liquid crystalline the fluorescence 
anisotropy of DPH decreases.53 This temperature-dependent decrease in anisotropy can then be plotted, 
and the phase transition temperature of the membrane discerned. Figure 3-6 Panel A shows that 
membranes containing 20% TMCL, 30% DMPC, and 50% DMPG are largely in the liquid crystalline 
phase when at 37 ºC.   
Once the phase transition temperature was determined an attempt was made to run the pyranine-based 
pore forming assay on membranes containing 20% TMCL. Unfortunately, the 20% TMCL LUVs eluted 
from the size exclusion column without retaining any encapsulated pyranine; it is likely that 20% 
TMCL liposomes are unstable and therefore fell apart in the column because of this finding it was 
decided to try using 10% TMCL containing LUVs. The DPH assay showed that these LUVs were also 
in a liquid crystalline phase by 37 ºC. The pyranine-based pore forming assay worked quite well (Figure 
3-6 Panel C); it was observed that at 2 µM dap 10% TMCL containing LUVs inhibit dap pore formation. 
This finding supports the conclusions of Zhang et al. (2014), namely that the CL heasgroup has 
inhibitory activty.20 The oligomer subunit stoichiometry and translocation assays were also run in order 
to ascertain if 10% TMCL containing membranes inhibited dap pore formation via the same mechanism 
as observed on 10% TOCL membranes. The results in Figure 3-6 Panel D show that the subunit 
stoichiometry and translocation results obtained on 10% TMCL membranes resemble those obtained 
on equal part DOPC: DOPG and 10% DOPC, 40% DMPC, and 50% DMPG LUVs. This suggests that 
the inhibition of pore formation by 10% TMLC membranes occurs via the same mechanism as 
inhibition on DOPC: DOPG membranes.   
 
Similar experiments were carried out at 10 µM dap.  At this concentration, dap easily permeabilizes 
inhibitory membranes even without the presence of CCCP suggesting that at high concentrations dap 
can transport protons. The subunit stoichiometry and translocation data mirror the pyranine-based pore 
forming assay results as the subunit stoichiometry increases and the distribution of dap between 





Figure 3-6. Determining the inhibitory effect of CL on daptomycin pore formation. Panel A shows the 
DPH assay for membrane fluidity. Panel B shows the pyranine-based pore forming assay results on 
10% TOCL LUVs. Panel C shows the pyranine-based pore forming results on 10% TMCL LUVs. Panel 
D details the experimental results of the oligomer subunit stoichiometry and translocation assay results 
at different dap concentrations on 10% TMCL containing LUVs.  
 
 
3.3.7 Is inhibition of dap by lipid acyl tails influenced by the nature of dap’s own acyl 
tail?  
Research by Debono et al. (1988) showed that dap analogs with longer and branched acyl moieties had 
increased antimicrobial activity. The purpose of this experimental work was to determine whether these 
modifications would allow to observe cation-selective pore formation on membranes that were found 




To answer this question two dap derivatives were made, and their pore forming ability was tested by 
the pyranine-based pore forming assay. C14 dap has the decanoyl fatty acid tail replaced with a myristoyl 
fatty acid tail and ante-dap has an ante-iso dodecanoyl acyl tail instead.  
Figure 3-7. C14-daptomycin permeabilization of DOPC: DOPG LUVs. The assay was completed as 
detailed in the previous chapter.  
Figure 3-8. Ante-daptomycin cation-selective permeabilization of DOPC: DOPG LUVs. The assay was 
completed as detailed in the previous chapter. The curves are offset by 10 seconds to minimize line 
overlapping. 
 
As evident from Figure 3-7 and 3-8 at low concentrations (3 µM) neither derivative of dap formed 
cation-selective pores on DOPC: DOPG LUVs. Overall, because this study was not exhaustive it cannot 
be argued that dap acyl tail moiety branching, or increased length might not overcome the inhibitory 




































This chapter focused on analyzing in greater detail how the mechanism of how phospholipid acyl tails 
modulate dap’s action mode in geater detail. Through this work it was found that: 
• Oleoyl acyl tails inhibit dap pore formation regardless of the headgroup moiety they are ligated 
to. 
• Inhibition of dap pore formation by oleoyl acyl tails is correlated with increased acyl tail length 
rather than lipid acyl tail unsaturation. 
• Inhibition of dap cation-selective pore formation occurs on membranes with low concentrations 
of oleoyl acyl tails (10 mol%). 
• Additionally the findings made by Zhang et al. (2014) regarding the ability of cardiolipin to 
inhibit dap cation-selective pore formation were confirmed; the CL headgroup does indeed 
inhibit dap’s ability to permeabilize membranes.20 
• In all the cases it was observed that phospholipid inhibition of dap cation-selective pore 
formation was caused the ability of oleoyl acyl tails to restrict dap octamer formation. The lack 
of octamer formation resulted in asymmetrical distribution of dap tetramers on membrane 
leaflets with most of the dap’s tetramers are located on the outer membrane leaflet.  
    
It is important to point out that the correlation between increased acyl tail length and inhibition of dap’s 
action mode corresponds to in vivo findings.  Both Hines et al. (2017) and Boudjemaa et al. (2018) 
observed, by mass spectroscopy lipidomic analysis, that clinically derived dap resistant bacteria have 
higher proportions of phospholipids with increased acyl tail length.54,55 Directly comparing in vivo  and 
in vitro results is cautioned as the model system of this study does not match the complexity of a 
bacterial membrane. Future experimental work could focus on corroborating the above findings on a 
membrane system more closely resembling a bacterial cytoplasmic membrane.  
 
Lastly, in the first chapter of this thesis, it was mentioned that Seydlová et al. (2018) observed dap 
cation-selective pore formation to be dependent on membrane potential. Seydlová et al. (2018) began 
their conductance experiments with a membrane potential of 10 mV, and subsequently increased it by 
regular increments until they reached the physiological value of 150 mV; as they increased the 
membrane potential to 150 mV, they observed a concomitant increase in the number of dap molecules 
per pore, the pore diameter, and accordingly the rate of cation transport through the pore. Based on 
their data and subsequently its analysis, Seydlová et al. (2018) concluded that dap’s cation-selective 
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pore consists of an octameric oligomer composed of two tetrameric oligomers conjoining across 
opposing membrane leaflets.16 Their findings mirror those of this study, but the reader must be 
cautioned to not directly compare them for two reasons; firstly Seydlová et al. (2018) conducted their 
experiments on membranes  composed purely of diphytanoyl-PG ( PG with two saturated and highly 
branched acyl tails), and the observation that a membrane potential may facilitate dap pore formation 
on membranes that are not permeabilized in its absence is important. It seems possible that the 
membranes that were found to be resistant to dap under the conditions of this study would also have 


























Chapter 4           
                
Characterization of lipid nanodiscs as a membrane model for 




Abstract: Although dap itself was discovered nearly 40 years ago; its membrane-bound structure 
remains unknown. Several attempts have been made to determine the structure by solution-state nuclear 
magnetic resonance, but they failed because no membrane mimetic possessing all the required 
physiochemical properties could be found. This study investigates the suitability of lipid nanodiscs 
stabilized by styrene-maleic acid co-polymers for structural studies on dap’s membrane-bound structure 
by solution-state NMR. Through the course of this work, it was observed that nanodiscs with a diameter 
small enough for solution-state NMR studies could be formed from equal DMPC: DMPG MLVs in the 
presence of 3 mM calcium. These nanodiscs had physiochemical properties remarkably similar to those 
observed on LUVs with the same phospholipid composition. Unlike a previously characterized bicelle 
system of similar lipid composition, the nanodiscs did not precipitate upon addition of calcium and dap 
(100 µM) and allowed for dap oligomerization. 1H-NMR studies showed that dap, indeed, binds to the 
nanodiscs, and yields spectra of sufficiently high resolution for structure determination. Overall, the 
styrene-maleic acid co-polymer stabilized lipid nanodiscs were found to be a promising system for 
determining dap’s membrane-bound oligomeric structure.   
4.1 Introduction 
Dap’s action mode remains partially contested because its membrane-bound structure has yet to be 
solved at an atomic level of resolution. Previous attempts to determine the membrane-bound structure 
by solution-state NMR have either utilized membrane mimetics lacking PG or were done in the absence 
of calcium. It is well established that both PG and calcium are required for dap to form oligomers, 
                                                   
4 The experimental work presented in this chapter was done solely by the author of this thesis. The experiments 
were designed by the author of this thesis, Dr. Michael Overduin, Dr. Thorsten Dieckmann, and Dr. Michael 
Palmer. The polymers were a gracious gift from the lab of Dr. Michael Overduin currently at the University of 
Alberta. Lastly, we thank Dr. Scott Taylor and his laboratory for the synthesis of NBD-dap.  
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which are in turn necessary for bactericidal activity, and the authors of those studies acknowledge that 
conducting experiments in the absence of PG and/or calcium will not yield biologically relevant 
structures, but they believe that some structural information is better than none.37 They were forced to 
take this course of action because previous studies found that at upon mixing of dap, calcium, and a PG 
containing membrane mimetic at concentrations required for solution-state the spectra had significant 
linewidth broadening and were consequently useless for structure determination.37 Unpublished studies 
by the Palmer and Dieckmann groups at the University of Waterloo, also found that at concentrations 
required for solution-state NMR studies, dap, calcium, and PG instantaneously precipitate.56  
 
While other structural elucidation methods, like X-ray crystallography, could be used to determine the 
structure solution-state NMR is preferred because it is the only methodology that allows for 
experiments to occur at temperatures that maintain membranes in the fluid liquid crystalline phase. 
Determining the structure on fluid membranes is important because acquisition of the most biologically 
relevant data is desired. The importance of maintaining a semblance of in vivo conditions is underscored 
by the work presented in the previous two chapters, which strongly suggests that dap’s membrane-
bound conformation is sensitive to its surrounding membrane environment.13,57   
 
Ultimately, solving dap’s membrane-bound structures requires finding a membrane-mimetic that 
contains PG, remains soluble, and does not aggregate after formation of the dap, calcium, and PG 
complex. The purpose of the work presented in this chapter was to assess if lipid nanodiscs stabilized 
with SMA copolymers meet these requirements, and could therefore be used for the determination of 
dap’s membrane-bound oligomeric structure, at the atomic level, by solution-state NMR.58  
 
4.1.1 Membrane-associated peptide/protein structure determination by solution-state 
NMR  
Determining the atomic level structure of almost any membrane-associating protein or peptide by 
solution-state NMR is an arduous task, and for two reasons: firstly solution-state NMR spectral 
resolution is dependent on the size of the molecule or assembly being studied, and second solution-
state NMR has limited sensitivity and thus requires high sample concentrations.59,60 Solution-state 
NMR spectral resolution is dependent on peak linewidth, which is inversely proportional to spin-spin 
relaxation time; spin-spin relaxation time (T2) describes how fast transverse magnetization de-phases. 
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The rate at which dephasing occurs is inversely proportional to the rotational correlation time (τc) of 
the molecule being studied.60,61 For proteins τc can approximated by treating the protein as a sphere, 





where r is the radius of the protein, KB is the Boltzmann constant, T is temperature, and η is the viscosity 
of the solvent.59  The equation above shows that larger proteins yield spectra with broader linewidths. 
The size constraint of solution-state NMR becomes an issue for highly soluble proteins with a molecular 
weight greater than 60 kDa, as at 60 kDa the protein’s radius is too large; thus,  giving rise to long τc 
and significant line broadening.60  
Determining the structure of a 60 kDa membrane-associating protein by solution-state NMR is even 
more difficult. Not only is the 60 kDa membrane-associating protein itself approaching the size limit 
of solution-state NMR, but obtaining a biologically relevant structure requires the use of membrane 
bilayer.62  Membrane bilayers, on their own without embedded protein, have diameters far too large for 
NMR structural studies; embedding proteins into them further increases their diameter. Since the 
proteins embed themselves into the bilayer their effective τc is now equal to τc of the protein-lipid 
complex, which is long, resulting in spectra with broadened peaks from which little information, 
structural or otherwise, can be gleaned.59  
Additionally, solution-state NMR is an inherently insensitive technique. One way to overcome the lack 
of sensitivity is to use high protein/peptide concentrations. With membrane-associating proteins and 
peptides this rarely works because at high concentrations the protein-lipid complex frequently 
precipitates.60  
4.1.2 Previous attempts to determine dap’s membrane-bound structure 
Determining dap’s oligomeric structure by solution-state NMR was previously hampered because at 
concentrations required for solution-state NMR spectra, daptomycin, calcium, and PG formed 
complexes that had large diameters, which consequently yielded spectra unusable for structure 
determination.37,56 To circumvent complex formation, attempts were made to determine the structure 
on membrane mimetics lacking PG; it was hoped that less line broadening would be occur: 
For example, structure determination experiments were conducted utilizing micelles composed of 1,2-
diheptanoyl-sn-glycero-3-phosphocholine (DHPC).37 The determined structure was found to be like 
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that of apo-daptomycin (no calcium bound). The lack of a major conformational change in the structure 
suggests that these micelles do not sufficiently mimic susceptible membranes. The first issue with using 
exclusively DHPC containing micelles is that there is a complete lack of PG. Consider the CD studies 
that show daptomycin to undergo a major conformational change upon binding PG, and the experiments 
by Muraih et al. (2011), in which oligomer formation was observed to occur only in the presence of 
PG.6,9 Combining the findings from these two experiments allows one to state that PG is required for 
dap to undergo a change in conformation, therefore, removing PG makes any structure determination 
experiments futile. Furthermore, DHPC has extremely short acyl tails, and consequently the monomeric 
membrane-bound daptomycin will still be partially in solution, and the determined structure will not be 
representative of dap’s membrane-bound state.   
Attempts were made to determine dap’s structure on PG containing micelles, but at the concentrations 
required for solution-state NMR dap, calcium, and the PG containing micelles precipitated out of 
solution.56   
4.1.3 Styrene-maleic acid co-polymers  
It is evident that previous attempts to solve dap’s structure failed because it was not possible to 
circumvent the two major obstacles of solution-state NMR: its low sensitivity and size restrictions.  The 
low sensitivity forced experimenters to use millimolar concentrations of dap that resulted in 
precipitation issues on biologically relevant membranes, and the size limitations forced the use of a 
poor membrane mimetic, just because it was the only system with a sufficient τc.
37,56 Ultimately, solving 
dap’s structure requires either increasing the sensitivity of NMR, no small task, or finding a membrane 
mimetic that has a short τc and remains soluble at concentrations of dap, calcium, and PG sufficient for 
solution-state NMR structural studies.   
Literature about the recently developed styrene-maleic acid (SMA) co-polymer-based membrane 
nanodisc system suggests that it possess all the qualities required to determine dap’s membrane-bound 
structure. The polymer converts proteo-liposomes and other membrane-protein containing membrane 
systems into small protein containing bilayer cylinders enveloped by SMA polymer.63 Such nanodiscs 
have a diameter less than 20 nm, which is small enough to obtain legible solution-state NMR spectra. 
The polymer is quite promiscuous converting almost any membrane system to nanodiscs, the nanodiscs 
have physiochemical properties similar to natural membranes, and the protein containing nanodiscs are 




4.1.3.1 Action mode of Styrene-maleic acid co-polymers  
SMA co-polymers act as scissors by dicing up large membranes into monodisperse nano-sized circular 
bilayers.63,64 The co-polymers are linear chains composed of repeating units containing styrene and 
maleic acid moieties; the arrangement of styrene and maleic acid within a monomeric unit is dependent 
on the synthesis method (see Figure 4-1, Panels A and B).58 It is proposed that SMA co-polymers form 
lipid nanodiscs via a three-step mechanism 65:  
1. The polymer initially binds the membrane in a concentration-dependent fashion. The binding is 
driven by hydrophobic interactions between the styrene moieties of the polymer and the lipid 
acyl tails of the membrane. Monolayer membrane experiments show that the hydrophobic 
interactions are so energetically favorable that they compensate for any unfavorable electrostatic 
interactions between the maleic acid and anionic lipids in the membrane.65   
2. After initial binding the polymer inserts deeper into the membrane. Optimal insertion is observed 
at the membrane’s Tm; it is presumed that at Tm the lipids are segregated into fluid and gel patches 
giving rise to lipid packing irregularities. These packing irregularities are thought to facilitate 
polymer penetration into the bilayer. Once inserted into the bilayer the process of solubilization 
begins; the process is kinetically driven as it can be sped up by increasing temperature.65 
3. The last step of the process involves the polymer completing membrane solubilization and 
nanodisc formation. As mentioned earlier, structural studies of SMA co-polymer stabilized lipid 
bilayers found that circular nanodiscs are formed (see appendix C for a schematic of a SMA 
stabilized nanodisc). The circular structure arises because the styrene moieties intercalate 
between the lipids. The intercalation of the styrene moieties into the bilayer decreases styrene 
electrostatic shielding on the polymer backbone; consequently Coulombic repulsion between 
maleic acid moieties causes the polymer to become curved.65 
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4.1.3.2 Types of Styrene-maleic acid lipid co-polymers  
There are a vast variety of styrene-maleic acid co-polymers that can be used to make lipid-containing 
nanodiscs. For each situation, the polymers are engineered to provide optimal performance (see Figure 
4-1, Panel A).  Generally, polymers are produced by one of two methods: either by conventional radical 
polymerization or reversible addition fragmentation chain transfer. The method of synthesis has been 
found to regulate polymer chain length and the arrangement of styrene and maleic acid within a 
monomeric unit (see Figure 4-1, Panel B).66 The optimal ratio of styrene to maleic acid moieties within 
a polymer is between 2:1 and 3:1; at these ratios the polymer has enough hydrophobic character to 
interact with the membranes while remaining soluble over a broad pH range. Additionally, the 
carboxylic acid side chains of maleic acid can be modified to change the pH profile in which the 
polymer functions, and also limit chelation of divalent cations (see Figure 4-1, Panel A).   
 
Figure 4-1. Structures of styrene-maleic acid co-polymers. Panel A shows the monomeric units of two 
types of SMA co-polymers: the one of the left is the generic SMA co-polymer with  n  usually equal to 
2 and m equal to 1, and the one on the right being a low cation chelating SMA co-polymer with 
ethanolamine ligated to one of  the two carboxylic acid side chains. Panel B shows possible 
arrangements of styrene (S) and maleic acid (M) within a monomeric unit of the polymer; these depend 
on the synthesis methodology used to create the polymer.  
 
 
The next two sections discuss the factors thought to influence the formation and properties of nanodiscs. 
The discussion is broken into two parts; the first deals with the effects of lipid composition on nanodisc 





nanodisc formation is likely influenced by both factors at the same time, here they are discussed in 
isolation because their combined effects on nanodiscs formation have not be studied systemically. 
4.1.3.3 Effect of lipid acyl tails on nanodisc formation 
One of the first things that was done when the SMA polymers were first developed was to determine 
whether membrane composition influences nanodisc formation. Experiments by Arenas et al. (2016) 
studied SMA solubilization kinetics by 31P solution-state NMR and nanodisc size by dynamic light 
scattering.67 They found that when membranes, composed either purely of POPC or 70 mol% POPC/ 
30 mol% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), were treated with excess 
polymer the resulting nanodisc size was the same.67 They do state that their polymers bind membranes 
containing lipids with smaller headgroups (30 mol% POPE) more avidly, but take longer to solubilize 
them into nanodiscs.67 Their finding suggests that phospholipid headgroups do not  influence nanodisc 
diameter. Scheidelaar et al. (2015) found that acyl tail length and unsaturation do not influence nanodisc 
size but do affect solubilization kinetics.65   
4.1.3.4 Effect of SMA architecture on nanodisc diameter 
One of the most important things when designing polymers with the intention of using the resulting 
nanodiscs in solution-state NMR studies is to engineer the polymer is such a fashion that the nanodiscs 
have a suitable diameter. Unfortunately, how SMA polymer architecture determines nanodisc diameter 
is not well understood; such is the situation because studies on this topic are not systematic – they are 
carried out on different polymers.65   
 
The effect of polymer architecture on nanodisc diameter was investigated. Smith et al. (2017) treated 
membranes with excess concentrations of variable length SMA and tested the resulting nanodisc 
diameter by size exclusion chromatography. They observed no correlation, positive or negative, 
between polymer length and nanodisc size.66  Interestingly, the number of styrene residues per unit 
length, and the polymer to lipid ratio can be used to control nanodisc diameter.55,57,58  Craig et al. (2016) 
found that at similar polymer concentrations, polymers with different ratios of styrene and maleic acid 
per monomeric unit produced nanodiscs of various sizes.68 Smith et al. (2017), conducted similar 
studies and propose that the conformation of the polymer in solution influences the rate at which 
membranes are solubilized; polymers with less hydrophobic character are not clumped in solution, 
which allows them to better penetrate the membrane and thus have a greater rate of solubilization.66 
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Lastly, Hall et al. (2018) observed that increasing the polymer to lipid ratio can be used to decrease 
nanodisc size.69 Hall et al. (2018) suggest that as polymer concentration increases the number of 
nanodiscs. While they do not explain why the number of nano-discs increases concomitantly with 
polymer concentration, it is likely that the size/number of nanodiscs self-adjusts such that the overall 
collective hydrophobic surface of lipid molecules that is in contact with the polymer matches that of 
the polymer itself; therefore, as polymer concentration increases it can cover increasing hydrophobic 
area.  
 
The mono-dispersity of nanodisc size suggests that all nanodiscs contain roughly the same numbers of 
lipids.  It is likely that whilst forming the nanodiscs are undergoing lipid exchange through fusion and 
fission processes in order to reach an equilibrium distribution of lipids. In addition because the system 
wants to obtain the most favorable Gibbs free energy (achieved by forming more nanodiscs) the 
exchange of lipids between nanodiscs continues until the largest possible number of nanodiscs is 
formed; achieving this requires that each nanodisc contain the  minimum has a decreased diameter.69   
 
All the trends discussed in this section were obtained from experiments in which only the ratio of 
polymer to lipid was varied; pH, temperature, and buffer/salt concentration remained constant. This is 
highly important because pH, temperature, and buffer/salt concentrations have been shown to affect 
SMA activity.58   
4.1.3.5 Effects of pH, temperature, and salt concentration on SMA solubilization activity 
It is very important to consider the pH at which an SMA co-polymer will be used.58 It has been shown 
that the maleic acid moieties on SMAs have their first pKa between 4 and 6 and their second pKa 
between 8.6 and 9; the exact values are  dependent on the styrene content in the polymer.70 Working at 
a low pH, where the maleic acids are not charged, will lead to polymer aggregation and precipitation. 
Working at too high a pH, where all the maleic acids are ionized, is also detrimental because the 
polymer will not bind to membranes due to electrostatic charge repulsion. Therefore, it important to 
fine tune the pH to obtain minimal polymer clumping whilst also not making interactions with 
membrane too electrostatically unfavorable.70   
The role of temperature was alluded to earlier in section 4.1.3.1. It is generally accepted that 
nanodiscs form best when polymer is added to lipid bilayers at their phase transition temperature. At 
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this temperature, patches of fluid and gel-state bilayer coexist, and the borders between them give rise 
to cracks in the membrane. These cracks facilitate the polymers’ insertion into the membrane.65  
The effects of buffer and salt concentration on polymer activity have also been well studied. Generally, 
binding of polymers to membranes requires salt; salt reduces electrostatic repulsion between them 
through Debye charge screening.70 Care must be taken when working with cations such as magnesium 
and calcium because the maleic moieties chelate these cations forming a hydrophobic complex that 
rapidly crashes out of solution.58 There are new SMA derivatives with reduced polymer chelation; in 
these polymers the maleic acid carboxylic moiety is ligated to something like ethanolamine (see Figure 
4-1 Panel A).58 
4.2 Materials and Methods 
4.2.1  Preparation of MLVs and nanodiscs 
Lipids used to make MLVs were acquired from either Avanti Polar Lipids (Alabaster, Alabama) or 
Larodan (Slona, Sweden). Lipids included 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-
dimyristoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt; DMPG; from Larodan), 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC), and dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium 
salt; DOPG). MLVs preparation was adopted from Skoza et al. (1980).71 The requisite amounts of lipids 
– equimolar mixtures of PC and PG were used in each case – dissolved in chloroform/methanol (3:1) 
and dried under N2 in a round-bottom flask. After removal of chloroform, the film was placed on a high 
vacuum overnight. The resulting lipid film was resuspended in pH 7.4, 10 mM HEPES (Biorad), and 
25 mM NaCl buffer (HBS). The resulting lipid suspension was vortexed at 24ºC intermittently over a 
1-hour period. MLVs were used at a final total concentration of 250 μM total lipid in the various assays 
unless stated otherwise. 
MLVs suspended in HBS were treated with polymer; the ratio of polymer to lipid was ranged from 3:1 
to 12:1 wt/wt%. The polymer was added dropwise. After polymer addition the sample was incubated 
at 28 ºC for 1 hour. The polymer used in these studies was a gift from the laboratory of Dr. Michael 
Overduin. The structure of the polymer or its name cannot be divulged at this time as the polymer is 
subject to a pending patent application. In this thesis, the polymer will be referred to as simply polymer. 
3, 9 and 12 polymer equivalents were used because of literature precedence.72  
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4.2.2 Dynamic Light Scattering (DLS) 
Dynamic light scattering measurements were conducted on a Zetasizer Nano ZS (Malvern Instruments 
Ltd.). Measurements were conducted in a 100 µL cuvette containing 500 µM of nanodiscs. To test the 
effects of calcium on nanodisc size some samples had 3 mM calcium added to the hydration buffer and 
upon mixing with lipid the sample rested for 10 minutes before addition of polymer. Other samples had 
3 mM calcium added 10 minutes after treating the membranes with polymer. Each trace is the average 
of 3 experiments each consisting of 10 consecutive acquisitions. The hydrodynamic radius was 
determined by using CONTIN software. All data were acquired at 28ºC; the samples were incubated 
for 1 hour after polymer addition at 28ºC before beginning data acquisition. Various calcium 
concentrations were tested, but 3 mM gave the most reproducible results.  
4.2.3 31P NMR measurements of nanodiscs with and without calcium 
The data were acquired on 500 MHz Bruker Avance spectrometer (Bruker Biospin, Rheinstetten, 
Germany) with a QNP probe operating at the 31P frequency of 202.5 MHz. A zg pulse, with a duration 
of 15 µsec at 0 db, was used to acquire 512 scans with a 2 second recycle delay. The data were analyzed 
on Topspin 4.0.6 where it underwent Fourier transformation and the chemical shifts were referenced to 
85% H3PO4 dissolved in D2O at 0 ppm. All data were acquired at 28ºC after the sample was incubated 
inside the spectrometer for 30 minutes. Samples consisted of 5 mM of nanodiscs (made as described in 
section 4.2.1) dissolved in HBS and 10% D2O. Calcium containing samples had 3 mM calcium added 
10 minutes after polymer treatment of the MLVs.  5 mM lipids were used because reproducible legible 
spectra could be acquired - other lipids concentrations were tested see Figure 1, Appendix D. 
4.2.4 Pyrene based assay for determination of nanodisc transition temperature  
4.2.4.1 Preparation of LUVs containing pyrene-PC 
All lipids used to make liposomes were acquired from Avanti Polar Lipids (Alabaster, Alabama), 
Larodan (Slona, Sweden), and Cayman Chemicals (Ann Arbor, Michigan). Lipids included 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC; Avanti), 1,2-dimyristoyl-sn-glycero-3-phospho-
(1'-rac-glycerol) (sodium salt; DMPG; Larodan), and 1-palmitoyl-2-pyrenedecanoyl 
phosphatidylcholine (pyr-pc). LUVs were prepared as described before. The requisite amounts of lipids 
– 0.5 mol% pyr-pc and an equimolar mixture DMPC/DMPG were dissolved in chloroform/methanol 
(3:1), dried under N2 in a round-bottom flask, and placed overnight on a high vacuum. The lipid film 
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was then resuspended in pH 7.4, 10 mM HEPES (Biorad), and 25 mM NaCl buffer (HBS), and the 
resulting lipid suspension was repeatedly extruded through a 100 nm polycarbonate filter. 
4.2.4.2 Preparation of MLV and nanodiscs containing pyrene-PC 
MLVs and nanodiscs were made exactly as described in section 4.2.1with the exception that 0.5 mol% 
(1-palmitoyl-2-pyrenedecanoyl phosphatidylcholine) was added to the chloroform: methanol mixture 
before lipid film formation.  
4.2.4.3 The experiment 
250 µM of LUVs or nanodiscs suspended in HBS were placed in a disposable cuvette. The cuvette was 
incubated at the corresponding temperature for 10 minutes, inside the spectrometer, before acquisition 
of pyrene’s fluorescence emission. The emission spectra (excitation wavelength: 335 nm; emission 
wavelength from 360 to 600 nm) were acquired on a PTI QuantaMaster 4 instrument. The data 
presented is the average of 3 independent experiments.  
4.2.5 31P NMR determination of nanodisc phase transition temperature  
The data were acquired as detailed in section 4.2.3.  p1 was set at 16.1 µsec with 0 db; 512 scans were 
acquired with a 2 second recycle delay. The data were analyzed as detailed in section 4.2.3. The 
linewidths were determined by the peak-width command in Topspin 4.0.6. Samples were incubated at 
the appropriate temperature inside the spectrometer for 30 minutes before acquisition. Samples 
consisted of 5 mM of nanodiscs (made as described in section 4.2.1) dissolved in HBS and 10% D2O.  
4.2.6 Monitoring daptomycin-membrane interactions by kynurenine fluorescence 
The assay was conducted as follows: 250 µM of DMPC/DMPG containing liposomes or nanodiscs 
were mixed with daptomycin (3 μM) and calcium chloride (0 to 10 mM final concentration) in HEPES-
buffered saline (10 mM HEPES, 25 mM NaCl, pH 7.4). Each sample was incubated for 3 minutes 
before data acquisition. Emission spectra (excitation wavelength: 365 nm) were acquired from 400 – 
600 nm on a PTI QuantaMaster 4 instrument. All trials were run in duplicate at 37ºC. 
4.2.7 Synthesis of 7-nitro2,1,3-benzoxadiazol (NBD)-labeled daptomycin 
The NBD-Dap used in these experiments was the same material that was used for experiments in 
chapter 2. The synthesis is described in section 2.2.1. 
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4.2.8 Daptomycin oligomer subunit stoichiometry  
Dap subunit stoichiometry was determined in the same way as described in section 2.2.7 with the 
following exceptions: the dap: NBD-dap ratio was keep constant at 4:1, 3 mM calcium, and 10 mM 
HEPES, 25 mM NaCl, pH 7.4 buffer were used instead of 5 mM calcium and 20 mM Hepes and 150 
mM NaCl. 
4.2.9 FRET-based assay of oligomer stability 
These experiments were adapted from Muraih et al. (2012).18 
Sequential Samples: 250 µM equal part DMPC: DMPG 9:1 polymer to lipid wt% nanodiscs in HBS 
(10 mM HEPES, 25 mM NaCl, pH 7.4) were treated with 3 mM calcium and 1 µM NBD-dap. After a 
3-minute incubation 4 µM dap was added to the sample and an emission spectrum was acquired. 
Another emission spectrum was acquired 7 minutes later. Emission spectra (excitation wavelength: 365 
nm) were acquired with detection between 400 – 600 nm on a PTI QuantaMaster 4 instrument. All 
trials were run in duplicate at 37ºC. 
Pre-mixed Samples: 250 µM equal part DMPC: DMPG 9 to 1 polymer to lipid wt% nanodiscs in HBS 
(10 mM HEPES, 25 mM NaCl, pH 7.4) were treated with 3 mM calcium and 5 µM mixture of 4:1 dap: 
NBD-dap. Emission spectra were acquired after 3-minutes of incubation and 10-minutes of incubation. 
Emission spectra (excitation wavelength: 365 nm) were acquired with detection between 400 – 600 nm 
on a PTI QuantaMaster 4 instrument. All trials were run in duplicate at 37ºC. 
4.2.10 Testing for inter-oligomer FRET between nanodiscs 
The dap: NBD-dap portion of the assay was done exactly at described in section 4.2.8. The dap only 
portion followed the same protocol as in section 4.2.8, with the exception that no NBD-dap was used; 
the initial addition consisted of 10 µM dap and the second addition consisted of 4 µM dap.  
4.2.11 Exchange of daptomycin oligomers between nanodiscs 
Initially, two samples were prepared: the first contained 5 µM Dap, 3 mM calcium, and 125 µM  
nanodiscs (9 polymer weight equivalents added to 1:1 DMPC:DMPG MLVs), and the second 
containing 5 µM NBD-Dap, 3 mM calcium, and 250 µM nanodiscs(9 polymer weight equivalents 
added to 1:1 DMPC:DMPG MLVs). Each sample was incubated for 3 minutes and then the 
fluorescence spectra were recorded. The samples were then mixed together, and fluorescence 
measurements were taken at regular time intervals. Emission spectra (excitation wavelength: 365 nm) 
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were acquired with detection between 400 – 600 nm on a PTI QuantaMaster 4 instrument. All trials 
were run in triplicate at 37ºC. 
4.2.12 Detecting daptomycin binding nanodiscs, stabilized by nine equivalents of 
polymer, via 1H solution state NMR 
The data were acquired on 600 MHz Bruker Avance spectrometer (Bruker Biospin, Rheinstetten, 
Germany) operating at the 1H frequency of 600 MHz. A zgesgp pulse program was used; p1 10.5 µsec, 
p16 1000 µsec, d16 .0005 sec, p12 2400 µsec, gpz1 31%, and gpz2 11%.  128 scans were acquired with 
a 1 second recycle delay. The data were analyzed on Topspin 4.0.6 where it underwent Fourier 
transformation. The chemical shifts were referenced to the water proton signal at 4.7 ppm. Samples 
were incubated at 28ºC inside the spectrometer for 30 minutes before acquisition. Nanodiscs were 
prepared as described above. Samples containing calcium had it added 10 minutes after addition of 
polymer. 10 mM Hepes, 25 mM NaCl pH 7.4 buffer was used in all samples. 10% D2O indicates that 
10% of the sample volume was D2O. The 100% D2O sample was prepared like all the other samples, 
but then lyophilized overnight and then rehydrated with only D2O. The polymer only sample contained 
9 equivalents of polymer dissolved in 90% HBS and 10% D2O. The dap only sample consisted of dap 
dissolved in 10% D2O and HBS. All samples were tested 1 hour after preparation.  
4.3 Results 
The polymer used in this study was recommended by Prof. Dr. Overduin after consideration of the 
problems previous encountered when attempting to determine dap’s membrane-bound structure by 
solution-state NMR. This specific polymer has been engineered to have reduced cation chelation, be 
gentle towards non-covalent interactions between proteins or peptides and possess superior solubility. 
The polymer is proprietary, and the author of thesis knows neither its exact composition, nor if it would 
indeed work in this application. 
4.3.1 Nanodisc hydrodynamic radius as determined by DLS 
As mentioned previously, the polymer used in this study is novel and uncharacterized. Consequently, 
the first step is to determine whether the polymer can convert PG and PC containing MLVs into 
nanodiscs with a diameter small enough to produce legible solution-state NMR spectra.  
The size of the nanodiscs was determined by DLS. DLS was chosen because it is widely used in the 
SMA field to characterize nanodisc size.65,73 The idea of using DLS to determine nanodisc size was 
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initially worrisome to many working in the field because DLS data analysis software calculates the size 
of particles assuming that they are spherical; nanodiscs are not.63,73 To determine whether this 
assumption yielded inaccurate data, DLS size measurements were compared to those obtained by 
various microscopy techniques with the comparison showing good agreement .73   
From Figure 4-2 it is evident that the polymer can convert MLVs containing equal parts of 
DMPC/DMPG into nanodiscs. It seems that 3 weight equivalents of polymer to one weight equivalent 
of lipid is not enough to induce formation of nanodiscs with diameters less than 20 nm; 20 nm being 
considered the maximal diameter at which NMR spectra of sufficient quality, for structure 
determination, can be obtained.74 Further the data suggests that in the presence calcium, regardless of 
the addition order, nanodiscs with a decreased diameter are formed.     
 
Figure 4-2: Diameter of nanodiscs containing lipid with and without calcium. Nanodiscs contained 1:1 
DMPC: DMPG and polymer in three-fold total excess over the lipid by weight. The diameter of the 
MLVs ≈ 85 nm. In the absence of calcium, nanodiscs have a diameter ≈ 33.5 nm. When calcium is 
added before the polymer, the resulting nanodiscs have a diameter centered at 21 nm; if polymer is 
added first nanodiscs have a diameter centered at 22 nm.  
 
As stated in the introduction, it is possible to decrease nanodisc size by increasing the polymer to lipid 
ratio.66 The data in Figure 4-3 suggests that increasing polymer equivalents does decrease nanodiscs 
size; nanodisc diameter decreased from 33.5 nm (three-fold total excess of polymer over the lipid by 
weight) to 7.25 nm (nine-fold total excess of polymer over the lipid by weight). The data in Figure 4-3 
shows that nanodisc diameter increases in the presence of calcium, but that the sequence of adding 
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samples progressively became hazy and at 10 mM precipitation occurred; precipitation occurred 10 
minutes after calcium (10 mM) addition to the sample. 3 mM calcium was chosen because it gave 
constantly reproducible nanodisc sizes and avoided precipitation. 
Figure 4-3. Diameter of nanodiscs with nine-fold total excess of polymer over lipid by weight with and 
without calcium. Nanodiscs contained 1:1 DMPC: DMPG and a nine-fold total excess of polymer over 
the lipid by weight. Diameter of the MLVs ≈ 85 nm. In the absence of calcium, the nanodiscs have a 
diameter ≈ 7.25 nm. When calcium is added first the resulting nanodiscs have a diameter centered at 
15.5 nm; if polymer is added first the resulting nanodisc have a diameter centered at 16.5 nm.  
4.3.2 31P NMR measurements of nanodiscs with and without calcium 
The above DLS data suggests that this novel polymer can create nanodiscs containing PG that in the 
presence of calcium retain a diameter sufficiently small for NMR. The purpose of these experiments is 
to use 31P NMR and see if well-resolved NMR signal can be obtained. As discussed earlier, solution-
state NMR is extremely size-sensitive.60 In the case of nanodiscs the size cut-off is around a diameter 
of 20 nm.74 From the DLS results, no signal is expected for nanodisc stabilized by a three-fold total 
excess of polymer over the lipid by weight as they are too large. On the other hand, nanodiscs stabilized 
by a nine-fold total excess of polymer over lipid by weight should produce legible spectra, since their 
diameter is less than 20 nm. 
31P NMR was used to corroborate DLS results because phosphorus NMR is one of the preferred 
methods to study membrane systems because 31P has 100% isotope abundance, it had a relatively high 
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Figure 4-4. 31P NMR of nanodiscs. Blue line: nanodiscs containing a three-fold total excess of polymer 
over the lipid by weight. Red line: nanodiscs containing a nine-fold total excess of polymer over the 
lipid by weight; PG peak: 0.8404 ppm; PC peak: -0.2567 ppm. Green line: nanodiscs containing a 
twelve-fold total excess of polymer over the lipid by weight; PG peak: 0.8002; ppm PC peak: -0. 2934. 
 
The first set of NMR experiments focused on studying the 31P signal of nanodiscs formed in the absence 
of calcium.  The data presented in Figure 4-4 corroborates the DLS results; nanodiscs formed by the 
addition of 3 polymer equivalents do not give rise to a 31P signal. This suggests that the nanodiscs are 
indeed greater than 20 nm in diameter. Nanodiscs formed by the addition of nine equivalents of polymer 
to lipid produce 31P spectra with significant intensity suggesting that the nanodiscs are smaller than 20 
nm in diameter. The phosphorus signal of nanodiscs formed by the addition of twelve equivalents of 
polymer was also tested. The signal intensity of these nanodiscs was slightly stronger than that 
nanodsics stabilized by nine-equivalents of polymer and the peaks were shifted upfield. The increase 
in signal intensity is likely a result of the decreased size; signal intensity is proportional to T2, which in 
turn is inversely proportional to particle size.60 The upfield shift can be attributed to chemical shift 
anisotropy; as the nanodiscs become smaller, more lipid molecules will directly interact with styrene 
group, which penetrate the lipid interface and their aromatic electrons cause shielding effects.67  
 
Figure 4-5 also corroborates the results obtained by DLS; upon addition of calcium the signal 
intensity decreases, and the peaks are shifted upfield. These are hallmark signs of increase in nanodisc 
size. The decrease in signal intensity is likely caused by a short T2. The change in chemical shift upon 
addition of calcium is likely due to calcium binding the lipids, which alters the chemical environment 
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of the phosphate phosphorus.77 Only the sample to which calcium had been added last was tested, since 
DLS had shown that the order of addition does not affect nanodisc size. Additionally, nanodiscs 
stabilized by a three-fold excess of polymer in the presence of calcium were tested; no signal was 
observed, suggesting that the nanodiscs are indeed greater than 20 nm in diameter; this is in agreement 
with DLS measurements.  Overall, the data suggests that nanodiscs stabilized with nine-equivalents of 
polymer have a diameter suitable for quality structural studies by solution state NMR. 
Figure 4-5. 31P NMR of nanodiscs with calcium. Blue line: nanodiscs containing a nine-fold total excess 
of polymer over lipid by weigh; PG peak: .8404 ppm; PC peak: -.2567 ppm; Red line: nanodiscs 
containing a nine-fold total excess of polymer over lipid by weigh  treated with 3 mM calcium added 




4.3.3 Determining the lipid bilayer phase transition temperature in nanodiscs  
Previous research work regarding dap’s action mode shows that dap is sensitive to its surrounding 
membrane environment.3,13,57 Therefore, it was important to determine whether nanodiscs have a phase 
transition temperature that is within a range suitable for solution-state NMR studies.  
4.3.3.1 Pyrene florescence  
Nanodisc phase transition temperature was determined by monitoring pyrene excimer fluorescence as 
a function of temperature. Pyrene is a fluorescent dye that has a long monomer lifetime allowing for 
efficient formation of excited dimers (excimers).78,79 While many fluorescent dyes can form excimers, 
the resulting fluorescence is rarely observed because it is not clearly separated from the monomer 
signal; in pyrene’s case the excimer signal is quite distinct.78,79 The formation of excimers requires that 
pyrene molecules collide through diffusion; consequently, the change in excimer signal reports on 
diffusion rates.80 In a membrane setting, since the pyrene is attached to a phospholipid acyl tail, the 
excimer signal reports on lipid collision frequency, which is dependent on membrane fluidity.80  
Figure. 4-5 shows that the excimer (E) to monomer (M) ratio mid-point for LUVs is at 30 ºC. This is 
higher than 24 ºC, the literature reported value for the phase transition temperature of equal part DMPC: 
DMPG LUVs.  The mid-point for nanodiscs, regardless of the amount of polymer added is slightly 
greater than 30 ºC. It is noteworthy that the excimer to monomer ratio is inversely related to polymer 
concentration; this is likely caused by several factors including styrene quenching of monomer pyrene 





Figure 4-6. Monitoring nanodisc phase transition by pyrene excimer formation.  On liposomes the phase 
transition temperature is 30 ºC and on nanodiscs, regardless of polymer concentration, it is slightly 
greater than 30 ºC.   
4.3.3.2 Using 31P linewidth to determine the phase transition temperature of nanodiscs 
It was expected that pyrene’s E/M ratio midpoint would correspond to the literature phase transition of 
24 ºC but evidently this was not the case. Consequently using another method to validate the transition 
temperature suggested by the midpoint of the E/M ratio was required. Previous research has found that 
phospholipid phosphorous linewidths, at half the signal intensity, are good reporters on membrane 
phase transition temperature.75,82,83 The NMR linewidth of phospholipid phosphate phosphorus atoms 
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Figure 4-7. Nanodisc phase transition temperature determined by 31P line width. The phase transition 
temperature of nanodiscs stabilized by addition of nine polymer equivalents is at 24.2 ºC.  
 
The apparent membrane phase transition temperature determined by phosphorus NMR is 24.2 ºC. 
Previous experiments show that the phosphate phosphorus linewidth reaches a global minimum value 
at the phase transition temperature of the lipid it is a part of and does not decrease any further; 
consequently, because the linewidths remain constant between 24.2 ºC and 32 ºC the phase transition 
temperature is not greater than 24.2 ºC.  Overall, the data suggests that the lipid phase transition 
temperature is not significantly affected by polymer. This suggest that nanodiscs have physiochemical 
properties like those observed on other membrane mimetics. This temperature range is sufficient for 
structural studies. Nanodiscs stabilized by the addition of nine weight equivalents of polymer were 
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4.3.4 Daptomycin binding to nanodiscs 
Once it was determined that nanodiscs created by the addition of nine polymer equivalents were small 
enough to produce legible NMR spectra, and the polymer did not increase lipid phase transition 
temperature it was time to determine the calcium concentration required for dap to bind to nanodiscs.  
Figure 4-8. Dap binding to nanodiscs monitored by kynurenine fluorescence. With increasing polymer 
concentration dap requires more calcium to bind the nanodiscs. This suggests that despite being 
engineered for minimal chelation the polymer the polymer can still bind calcium.  
 
Dap’s binding to nanodiscs was monitored by kyn fluorescence.27 It is evident from Figure 4-8 that 
with increasing polymer concentration more calcium is required to induce membrane binding; likely 
the polymer, despite being engineered for low calcium binding, still has affinity for calcium and 
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4.3.5 Daptomycin oligomer subunit stoichiometry on nanodiscs 
It is widely accepted that for dap to bring about is bactericidal effect it must form oligomers.3,18 
Consequently it is of the utmost importance that the membrane system used to determine the structure 
allows for dap oligomerization. Accordingly, the purpose of this experiment was to determine if dap 
could form oligomers on nanodiscs. 
Figure 4-9. Subunit stoichiometry of daptomycin oligomers on various membrane mimetics. On LUVs 
the subunit stoichiometry is 6.5 ±0.68, on nanodiscs stabilized by three polymer equivalents it is 7.4 ± 
0.33, and nanodiscs stabilized by nine polymer equivalents it is 4.4 ±0.11. 
 
From Figure 4-9 it is evident that LUVs and nanodiscs stabilized by three polymer equivalents have 
roughly the same number of subunits; around 8 subunits (see section 2.3.4 for a discussion why the 
subunit stoichiometry on DM membranes ranges from 6 to 7 subunts.) – presumably 4 per leaflet. On 
nanodiscs stabilized by nine polymer equivalents the stoichiometry is roughly half of 8. This is not an 
unexpected result, because at 3 mM calcium the kynurenine signal for nanodiscs stabilized by nine 
polymer equivalents is only about 60% of its maximal intensity, whereas for LUVs and nanodiscs 
stabilized by three polymer equivalents it is nearly 100%. In the case of nanodiscs stabilized by nine 
polymer equivalents, the polymer is binding calcium and limiting dap’s ability to undergo its second 
calcium binding event and subsequent octamer formation; it is highly probable that the subunit 
stoichiometry reflects the formation of the tetramer that is formed as a result of the first calcium binding 
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oligomers are not observed on nanodiscs small enough for NMR studies, the conditions would allow 
for the study of the tetramer, which would still be of significant interest.  
4.3.6 Verifying the assumptions of the subunit stoichiometry assay  
To determine the subunit stoichiometry several assumptions are made; that oligomers are stable on the 
time scale of the experiment, and that the second addition of dap is required to account for FRET 
occurring between olgiomers.18 
 
Figure 4-10. Daptomycin oligomer stability on nanodiscs stabilized by nine polymer equivalents. The 
dap only sample contained 4 µM dap and the spectra were acquired 10 minutes after its addition to 
nanodiscs (acquisitions were made at 3 and 5 minutes; they are identical to the 10 minutes trace). The 
premixed sample contained 1 µM NBD-dap and 4 µM dap (data acquisition was made at 3 minutes; it 
is identical to the 10 minutes trace). The sequential sample contained 1 µM NBD-dap and 4 µM dap 
added 3 minutes after.  
 
The findings in Figure 4-10 mirror those observed by Muraih et al. (2012). Pre-mixing NBD-dap and 
dap results in a kynurenine signal that is significantly less intense than observed with the native-dap 
only sample. This is because dap and NBD-dap are forming hybrid oligomers in which the kynurenine 
fluorescence is quenched by FRET.  The sequential addition of NBD-dap and dap results in increased 
kynurenine signal compared to the premixed sample; NBD-dap and dap form separate oligomers, and 
therefore the kynurenine signal is not quenched as strongly as the signal in the premixed samples. The 
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are stable and are not transiently exchanging dap molecules to form hybrid oligomers. As mentioned in 
section 2.2.7, the suppressed kynurenine fluorescence in the sequential sample compared to the dap 
only sample is due to kynurenine quenching occurring through FRET between oligomers. Overall, it 
seems that once oligomers form the comprising individual subunits do not transiently exchange.  
 
The sequential addition experiments suggest that the second addition of dap is needed to account for 
FRET between oligomers.  It is possible to test directly for this FRET by comparing the difference in 
signal between a second addition of dap to hybrid and dap only oligomers. 
Figure 4-11. Testing for FRET between daptomycin oligomers on nanodiscs stabalized by addition of 
nine polymer equivalents. The assay was done exactly like described by Muraih et al. (2012) with the 
exception that 3 mM calcium and 10 mM Hepes 25 mM NaCl pH 7.4 buffer were used.  
 
It is expected that if the difference in signal between a second addition of dap (red) to the mixed hybrid 
oligomers (blue) is smaller than the difference between the second addition of dap (purple) to dap only 
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blue and yellow and grey is the same, then there is no FRET between oligomers. Figure 4-11 shows 
that the difference between the purple and grey curves is greater than that between the red and blue 
curves, suggesting that there is FRET between oligomers. It is likely that the nanodiscs accommodate 
more than one oligomer per nanodisc; kynureinine and NBD FRET radius is too small for FRET to 
occur between nanodiscs.9 Overall, both the stability and inter-oligomer FRET assumptions required 
for stoichiometry calculation are correct. 
4.3.7 Exchange of daptomycin oligomers between nanodiscs 
Previous research on nanodiscs has shown that they exchange lipids by transient fusion and fission 
processes. The goal of these experiments was to determine whether dap oligomers can also be 
exchanged between nanodiscs. 
Initially, two samples are prepared: the first sample (just dap) contains nanodiscs treated with dap and 
calcium and the second sample (just NBD) contains nanodiscs treated with NBD-dap and calcium. Each 
sample is incubated, and the fluorescence spectrum is recorded. The samples are then mixed together, 
and fluorescence measurements are taken at regular time intervals. If the nanodiscs do not undergo 
fusion, then the spectra recorded after mixing should look like a linear combination of the two samples 
before mixing. On the other hand, if there is fusion and oligomer exchange, then the spectra recorded 
after sample mixing should show diminished signal intensity for kynurenine because of inter-oligomer 
FRET to oligomers made of only NBD-dap.   
Figure 4-12. Daptomycin oligomer exchange between nanodiscs. The just dap sample contained 5 µM 
Dap, 3 mM calcium, and 125 µM nanodiscs. The just NBD-dap sample contained 5 µM NBD-Dap, 3 
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The immediate decrease in kynurenine signal intensity upon mixing of the two samples suggests that 
nanodiscs undergo rapid fusion and exchange oligomers. The measurements taken at different time 
intervals after mixing are almost identical suggesting that the process of nanodisc fusion and oligomer 
exchange is rapid and quickly reaches an equilibrium.  
4.3.8 Observing daptomycin binding to nanodiscs, stabilized by addition of nine 
polymer equivalents, by 1H-NMR 
The goal of this experiment was to determine whether nanodiscs stabilized by 9 polymer equivalents 
treated with dap and calcium yield legible 1H spectra.  
Figure 4-13. 1H-NMR spectra of daptomycin interacting with nanodiscs stabilized by nine polymer 











The amide region (>6 ppm) of dap (purple) is quite clear without the presence of nanodiscs (blue and 
green). Upon addition of nanodiscs (green) characteristic dap peaks are overshadowed by the aromatic 
styrene protons of the polymer (also seen in the polymer only sample; red). In the 2.8 – 3.8 ppm region 
of the spectrum dap peaks in the absence of nanodiscs (purple) shift. Upon addition of nanodiscs, dap 
peaks decrease in intensity and broaden out slightly; this is an indication of dap binding to the 
nanodiscs.  Between 1.0 to 2.2 ppm a new peak appears at 2.15 ppm in the 100% D2O sample, which 
may represent an exchangeable alcohol or amine. Overall, the 1H data suggests dap is binding to the 
nanodiscs. While the signals obtained from nanodisc-bound dap are broadened, the extent of 
broadening does not render the peaks unusable for structure determination. Lastly, all the NMR samples 
were stored for over a week and no precipitation was observed; this result indicates that this system is 
very stable and is amenable to the long experimental times of NMR.  
4.4 Discussion 
The motivation for the work reported was to assess the suitability of using styrene-maleic acid lipid co-
polymer nanodiscs to determine dap’s membrane-bound structure. The study began with determining 
whether the polymer in question could form nanodiscs, from MLVs composed of equal parts DMPC: 
DMPG and in the presence of calcium and whether these discs were small enough to produce well-
resolved NMR spectra. By using DLS and 31P it was possible to determine that nine weight equivalents 
of polymer per one weight equivalent of lipid is required to create nanodiscs that are composed of 
DMPC: DMPG, stable in presence of calcium, and produce legible NMR spectra. The nanodisc gave 
the most reproducible results when 3 mM calcium was used; likely because 3 mM calcium was not 
enough to induce precipitation. During these studies it was observed that addition of calcium influenced 
nanodisc size. The effects of calcium and magnesium on SMA nanodisc size have been studied Before 
but with a different polymer; consequently, the results are not comparable.84  After determining that 
Colour Calcium (3 mM) Nanodiscs with lipid D2
O Dap (100 µM) 
Blue Yes Yes 100% Yes 
Red No Polymer only  10% No 
Green Yes Yes 10% Yes 
Purple Yes No 10% Yes 
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nanodiscs of sufficient diameter can be formed in a system that contains both calcium and PG, it was 
important to study their physiochemical properties.  The phosphorus line width data suggests that  nine 
weight equivalents of polymer nanodiscs containing 1:1 DMPC: DMPG have a phase transition around 
24.2 °C; this is not dissimilar to values reported in literature for LUVs with the same lipid 
composition.75,83 
  
The phosphorus NMR results further suggest that phospholipids with pyrene labeled acyl tails are 
reporters of lipid lateral diffusion rather than membrane phase transition temperature. On LUVs the 
excimer to monomer ratio begins to increase significantly only after 24.2 °C. This a surprising, until 
consideration is given to the process of excimer formation. It is well known that excimers can only 
form if two pyrene molecules are within several angstroms of each.79  In a membrane setting the 
formation of excimers would involve lipids undergoing free lateral diffusion until two lipid molecules, 
both containing pyrene, collide so as to bring their respective pyrene’s sufficiently close for excimer 
formation. Observation of stronger excimer signal would mean that the collision frequency between 
lipids is increasing. Increased collision frequency can only occur if lipids have free lateral diffusion, 
and free lateral diffusion can only begin in earnest when much of the membrane is in a fluid state. Much 
of the membrane reaches a fluid state only once the temperature of the system is significantly larger 
(this depends on the lipid composition of the membrane) than the phase transition temperature (Tm).
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This is because at Tm 50% of the membrane would still in a gel-like phase; the patches of gel-like lipids 
can hinder free lateral diffusion by acting as physical barriers and through sequestration of lipids that 
could partake in collisions. In this context is not surprising that on LUVs the excimer signal rises 
significantly only once the temperature of the systems surpasses the NMR determined and literature 
phase transition of roughly 24°C. 
 
On nanodiscs, regardless of polymer concentration, the increase in excimer signal begins at even higher 
temperatures than observed on LUVs. This could be because the polymers sequester pyrene-labelled 
lipids through pi-stacking interactions with the polymer styrene moieties; in this case the higher 
temperature is then required to give the pyrene lipid enough kinetic energy to disrupt this interaction 
and diffuse away. The decrease in excimer to monomer ratio at various temperatures between LUVs 
and nanodiscs can be attributed to the decreased amount of pyrene molecules per nanodisc. Each LUV, 
assuming a 100 nm diameter and a .7 nm2 average lipid headgroup surface area, has 1795 pyr-PC 
molecules per LUV.80 Each nanodisc stabilized by the addition of nine polymer equivalents, assuming 
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a 15.5 nm diameter and a .7 nm2 average lipid headgroup surface area, has 1.4 pyr-PC molecules per 
nanodisc leaflet. It is likely that less pyrene molecules lower the probably of collision and therefore the 
excimer signal. Additionally, on some nanodiscs the pyr-pc will have no other partner pyr-PC with 
which to interact and will never form excimers regardless of membrane fluidity. Another consideration 
is that styrene has been shown to be a dynamic quencher of pyrene. Dynamic quenching implies that 
the lifetime of monomeric pyrene decreases; consequently, in a system that contains styrene the excited 
monomeric pyrene molecules will have less time to find a partner pyrene and form an excited dimer.81  
On the other hand, the first mechanism proposed here (sequestration of pyrene by styrene) should cause 
static quenching, and thus reduce fluorescence intensity but not lifetime. Thus, fluorescence lifetime 
experiments should be able to distinguish between these two mechanisms. 
 
Once it was determined that nanodiscs stabilized by nine polymer equivalents have a phase transition 
temperature like LUVs with the same lipid composition, it was important to determine at what calcium 
concentration dap would bind the nanodiscs and whether dap oligomers would form. It was observed 
that dap readily oligomerizes on nanodiscs stabilized by addition of nine polymer equivalents at calcium 
concentrations which do not induce nanodisc precipitation. The FRET-based stoichiometry 
experiments showed that the oligomers formed were tetrameric and did not consist of transiently 
exchanging dap molecules. Dap octamers did not form, presumably because polymer and dap compete 
for the calcium. Additional work showed that the tetrameric oligomers transiently exchange between 
nanodiscs. 1H-NMR studies confirmed that dap binds to nanodiscs stabilized by addition of nine 
polymer equivalents in the presence of 3 mM calcium without significant line broadening. Altogether, 
this work suggests that the SMA-X-based nanodiscs are a promising membrane mimetic that could be 
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5.1 Conclusion  
The first two chapters of this thesis present data suggesting that phospholipid acyl tails influence dap’s 
ability to permeabilize membranes. Permeabilization was observed on membranes composed of 
myristoyl acyl tails, but not on those composed of phospholipids with palmitoyl or oleoyl acyl tails. 
Oleoyl acyl tails were found to inhibit dap membrane permeabilization regardless of the lipid headgroup 
they are ligated to. The gathered data indicate that oleoyl acyl tail inhibition correlates with increased 
acyl tail length rather than lipid unsaturation. Additionally, it was observed that oleoyl lipid acyls inhibit 
dap’s pore formation even at small membrane concentrations (10 mol%). It seems that oleoyl acyl tails 
inhibit dap pore formation by disrupting the formation of dap octameric oligomers; on oleoyl 
membranes most of the dap is located on the outer membrane leaflet with tetrameric dap oligomers 
being observed. The inhibitory effect of cardiolipin observed by Zhang et al. (2014) was reconfirmed 
in this study.20  In their experiments, Zhang et al. 2014) observed inhibition of dap pore formation on 
TOCL containing membranes; they argued that the observed inhibition was caused by the CL 
headgroup.20 This argument was made because they were unaware of the inhibitory effects of oleoyl 
acyl tails on dap’s action mode. In this study it observed that membranes containing TMCL, at 
concentrations used by Zhang et al. (2014), were also resistant to permeabilization by dap thereby 
confirming the finding by Zhang et al. (2014) that the CL headgroups does indeed inhibit dap’s action 
mode.20 It should be noted that TOCL membrane more strongly inhibit dap pore formation than TMCL 




The last chapter of this thesis investigated the use of styrene-maleic acid co-polymer membrane 
nanodiscs as membrane mimetics on which to determine dap’s membrane-bound structure by solution-
state NMR. It was observed that nanodiscs with a diameter sufficiently small to produce legible NMR 
spectra could be created from PG containing MLVs and in the presence of 3 mM calcium. The studies 
further showed that dap could bind to the nanodiscs and form partial tetrameric dap oligomers at 3 mM 
calcium.  Additionally, the nanodiscs did not precipitate when treated with higher concentrations of 
calcium and dap. Overall, these findings show that while the SMA polymer used in this study does not 
allow for full dap oligomerization, the partial structure of membrane-bound dap could still be obtained 
with this system by solution-state NMR.  
 
5.2 Future Work 
5.2.1 Effects of branched acyl tails on dap membrane permeabilization  
As mentioned earlier, bacterial cytoplasmic membranes have a significant number of phospholipids 
with branched acyl tails. Boudjemaa et al. (2018) found that bacteria resistant to dap not only increase 
the lengths of their lipid acyl tails, but also can alter the position of the branching.55 Therefore it would 
be interesting to conduct the exact same experiments as in chapters 1 and 2 with LUVs containing 
branched phospholipid acyl tails and corroborate the finding of Boudjemaa et al. (2018).  
5.2.2 Using a different SMA polymer to form membrane nanodiscs 
One major drawback of the current nanodisc system is that the polymer used competes with dap for 
calcium; consequently, allowing for only partial dap oligomerization. The issue of partial 
oligomerization could possibly be overcome by making lipid nanodiscs with a polymer with no calcium 
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Figure 1. HPLC trace of NBD-dap - section 2.2.1 
 




Figure 3. Dithionite quenching of NBD-PE on POPC: POPG LUVs 
Figure 4. Dithionite quenching of NBD-PE on DOPC: DOPG LUVs 
 
To make sure that dap could not enter the intra-LUV space via dap’s pore 0.5 % mol/mol NBD-PE was 
incorporated into liposomes containing either equal parts POPC: POPG or DOPC: DOPG.  250 µM of 
one type of LUV was incubated for 3 minutes. Fluorescence acquisition of the NBD signal was at 520 
nm (excitation 478 nm) was began and then dithionite (1 mM) was added. The experiment was repeated 
the same way for dap containing traces; in those cases, 2 µM dap and 25 mM calcium were added to 
the LUV sample and incubated for 3 minutes before starting data acquisition. 0.1% Triton X-100 was 
added to solubilize the liposomes. The experiments were done at 37ºC. Overall, dithionite does not 
enter the intra-LUV space of neither PO (Figure 3) and DO (Figure 4) containing liposomes. Refer to 































































Figure 5. Gram-positive bacteria cytoplasmic membrane composition.  
The figure shows a literature overview of the wide variety of phospholipid acyl tails found in the 





Figure 1. HPLC trace of NBD-dap - section 3.2.1 
 









































Figure 5. HPLC trance of ante C12-dap - section 3.2.3  
 
 











Figure 7. DPH anisotropy membrane fluidity assay 
DPH membrane phase transition assay. The phase transition temperature of membrane can be 
determined by using the fluorescent probe DPH; due to its hydrophobic nature DPH inserts into 
membranes and as the membrane transitions from the gel phase to the liquid crystalline the fluorescence 
anisotropy of DPH decreases. This data can then be used to discern the phase transition temperature of 
the membrane. Figure 7. shows that liposomes containing up to 20% DPDPC reach the fluid state by 
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Figure 1. Dependence of 31P NMR signal intensity on lipid concentration 
The red line is from a sample containing 1.25 mM equal part DMPG: DMPC containing nanodiscs 
stabilized by addition of nine polymer equivalents. The red line is from a sample containing 5 mM 
equal part DMPG: DMPC containing nanodiscs stabilized by addition of nine polymer equivalents. The 
5 mM samples were used because better signal intensity could be obtained with a shorter acquisition 
time. Refer to section 4.2.3.  
 















The green cylinder represents the lipid bilayer and the pink bands represent the SMA polymer 




Figure 1. Structure of dap derivatives. 
 
 
Daptomycin possess a decanoyl moiety. C14-dap has the decanoyl moiety replace with a myristic acyl 
tail. NBD-dap has an NBD attached (magenta) at the ornithine-6. Kynurenine, whose fluorescence is 
polarity sensitive is highlighted in green. The anteiso-dodecanoyl dap derivative has the decanoyl 























The structures of all lipids used in this study with their acronym:1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC), 1,2-dimyristoleoyl-sn-glycero-3-phosphocholine (DMPC ∆9-cis), 1,2-
Dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG), 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC),1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG), 1,2-dipentadecanoyl-sn-
glycero-3-phosphocholine (DPDPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG), , 1-palmitoyl-2-pyrenedecanoyl 
phosphatidylcholine (pyr-PC), 1',3'-bis[1,2-dimyristoyl-sn-glycero-3-phospho]-glycerol (TMCL), 
and 1',3'-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol (TOCL). 
 
 
 
 
